Correlation of Magnetic Resonance Imaging findings with MIB-1 Labeling Index for Intracranial Meningiomas by Vineesh, K Varghese
CORRELATION OF MAGNETIC RESONANCE IMAGING FINDINGS WITH 
MIB-1 LABELING INDEX FOR INTRACRANIAL MENINGIOMAS 
 
 
 
 
 
 
 
 
 
Dissertation submitted to the MGR Medical University, Chennai, for the Part III M.Ch. 
Neurosurgery Examination, August 2009. 
 
 
 
 
 
 
ii 
 
ACKNOWLEDGEMENT 
I am grateful to Professors Dr.  Ari G. Chacko and Dr. Vedantam Rajshekhar for all 
the encouragement, suggestions that helped me write this thesis and also for the 
valuable time spent during the observations. 
I would like to express my gratitude to Prof. Dr. Geeta Chacko who gave me the concept 
of this thesis and provided the data relating to the histopathological diagnosis and MIB-
1 labeling indices. 
I am thankful to Mr. Prasanna from Clinical Epidemiology Unit and Dr. Divya S.Iyer 
for helping me with statistics and tables for the thesis. 
I would like to thank my parents for all the support and encouragement they gave me 
when I needed them the most. 
 
 
 
 
 
 
 
 
 
iii 
 
Table of contents 
 
i. List of tables…………………………………………………… iv 
ii. List of figures……………………………………………………vi 
iii. Introduction……………………………………………………...1 
iv. Literature review…………………………………………………2 
v. Aims & Objectives……………………………………………….32 
vi. Hypothesis………………………………………………………..32 
vii. Materials & Methods……………………………………………..32 
viii. Results……………………………………………………………35 
ix. Discussion………………………………………………………...45 
x. Conclusion………………………………………………………..58 
xi. References………………………………………………………..59 
xii. Appendix  
 
 
 
 
 
iv 
 
List of Tables 
 Table 1: Distribution of Intracranial Meningiomas in Cushing’s series 
 Table 2: Summary of the 2007 WHO grading scheme for meningiomas 
 Table 3: Histologic and immunohistochemical features in prognosis 
 Table 4: Criteria for Radiological Scoring 
 Table 5: Correlation of MIB-1LI with histological grading 
 Table 6: Identification of perilesional edema by the two observers 
 Table 7: Peritumoral edema in correlation with MIB-1LI  
 Table 8: Various statistical parameters on significance of edema with respect to   
MIB-1LI 
 Table 9: Tumor-Brain Interface in relation with histological grade 
 Table 10: Tumor-Brain Interface in correlation with MIB-1LI 
 Table 11: Various statistical parameters of  tumor-brain interface with respect to    
MIB-1LI  
 Table 12: Tumor shape  in correlation with histological grading 
 Table 13: Cross tabulation  of  tumor shape with MIB-1LI 
 Table 14: Various statistical parameters on significance of tumor shape with MIB-1 
LI  
 Table 15: Combination of tumor-brain interface and tumor shape in comparison with 
the MIB-1 LI  
v 
 
 Table 16: Statistical significance of  edema, tumor-brain interface and tumor shape in 
correlation with MIB-1LI.  
 Table 17: Cross tabulation for peritumoral edema as per two observers 
 Table 18: Cross tabulation for tumor brain interface as per two observers 
 Table 19: Cross tabulation for tumor shape as per two observers 
 Table 20: Cross tabulation between the Total Radiological Scores of the two 
observers 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
List of figures 
 Figure1: Correlation between MIB1-LI and histological grading of meningioma 
 Figure 2: Observations on combination of tumor-brain interface and shape of tumor 
 Figure 3: T2w MRI showing a large meningioma with no peritumoral edema. 
 Figure 4: Parasagittal meningioma with disagreement on presence of edema between 
the observers 
 Figure 5: Meningioma with well defined tumor-brain interface  
 Figure 6: Meningioma with disagreement on tumor brain interface between the two 
observers. 
 Figure 7:  Showing a meningioma with irregular tumor shape  
 Figure 8: Showing a meningioma with disagreement on tumor shape between the two 
observers 
 
 
 
 
 
 
 
vii 
 
 
 
 
 
DEPARTMENT OF NEUROLOGICAL SCIENCES 
CHRISTIAN MEDICAL COLLEGE 
VELLORE 
 
 
 
 
CERTIFICATE 
 
 
 
 
This is to certify that the dissertation titled “Correlation of Magnetic Resonance Imaging 
Findings with MIB-1 Labeling Index for Intracranial Meningiomas” is the bonafide 
original work of Dr. Vineesh K. Varghese, submitted in partial fulfillment of the rules 
and regulations, for Branch-II M.Ch. Neurosurgery, Part-III examination of the Tamil 
Nadu Dr. M.G.R. Medical University to be held in August 2009. 
 
 
 
 
 
 
 
 
 
 
 
 
 Signature of the Guides 
 
 
 
 
 
Dr.Geeta Chacko                      Dr. Ari G. Chacko                   Dr. Vedantam Rajshekhar 
Professor of Neuropathology   Professor of Neurosurgery       Professor of Neurosurgery 
 
 
 
Department of Neurological Sciences, Christian Medical College, Vellore.  
 
1 
 
Introduction 
Meningiomas are the most common benign intracranial tumors accounting for 13-26% of all 
primary intracranial tumors.[1] Meningiomas often recur after seemingly complete removal, 
although they are benign, generally slow growing and apparently well circumscribed. 
Recurrence has been estimated to occur in 9 to 15% of benign meningiomas within 10 years 
after total removal. [2] Atypical and anaplastic meningiomas reportedly have higher 
recurrence rates (38% and 78% respectively). [2] Recurrences have been attributed to 
incomplete tumor removal and histological aggressiveness of the tumor.  The WHO Type II 
or Type III meningiomas are thought to recur because these invade the normal surrounding 
tissues and microscopic remnants of tumor cells that may be inadvertently left behind at 
surgery grow rapidly. Therefore it is essential that wide resection of dura around the site of 
tumor attachment is done. Extensive excision may leave a large dural defect, requiring dural 
grafting, and more importantly may cause neurological deficits depending on the tumor 
location and size. Therefore preoperative identification of high-risk groups in terms of 
biological behavior of meningiomas would be useful. A few studies in the past [3] have tried 
to predict the proliferating potential of meningiomas based on their preoperative MRI 
findings and three parameters namely, peritumoral brain edema, tumor-brain interface and 
shape of the  tumor had shown a correlation with MIB-1LI of the tumor.  
The present study was an attempt to correlate the above mentioned MRI characteristics with 
the MIB-1LI of the tumor, to see if a preoperative prediction of biological behavior of 
meningiomas was possible. 
 
 
2 
 
Literature Review 
History 
Cushing and Eisenhardt [4] in their famous monograph on meningiomas stated that 
meningiomas have left their unmistakable traces even on prehistoric skulls. This was the most 
accepted terminology after a series of names these tumors were designated with.  One of the 
first recorded names for this tumor is in Chapter XXI of a book written by Louis in 18th 
century where he calls these tumors Fungus Durae Matris. Richard Bright in “Reports of 
Medical Cases” (1831) stated that the tumor is a growth from the dura mater or rather from 
the arachnoid lining the dura matter. Cruveilhier in his ‘Anatomie Pathologique”  1835  
termed it “ Tumeurs fongueuses” and “ Tumeurs cancereuses des meninges” and in 1856  he  
questioned the acceptance of the tumor as malignant considering the fact that the tumor 
remained without invading the cerebral tissues for many years. In 1851, Hermann Lebert 
classified these tumors into those, that were cancerous, and those that were not. He called the 
non-cancerous ones as “tumeurs fibro-plastiques intracraniennes.  In 1854, Sir James Paget in 
his “Lectures on Surgical Pathology” classified these tumors to be “less malignant than 
cancer”.  Robert Virchow called these tumors ‘psammomomas’ based on the post mortem 
observation of “brain sand” accumulations in these tumors. Ludwig Meyer, Bouchard and 
Robin in 1859 substituted the name “epithelioma” considering that they arose from serous 
surfaces including arachnoid. In 1864 John Cleland described two tumors, which he had 
encountered in the dissecting room, one of them having arisen from the olfactory groove and 
the other from the right frontal region. Microscopically, these tumors were found to be rich in 
cellular concretions. They were found to be well separated from the dura mater and were 
named “villous tumors of the arachnoid” In 1865, with the renaming of the lining membranes 
as “endothelium”, Camillo Golgi suggested the term ‘endothelioma’ for these tumors.  
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Subsequently Kolliker called them “mesothelioma” around 1882 when the lining membranes 
had been named as Mesothelium.  The word meningioma came to usage for the first time in 
1922 by Harvey Cushing. 
 These tumors arise from the arachnoid cap cells, which are specialized clump of arachnoid 
cells that are exposed to the venous blood of dural venous sinus.[5]  The latest name for the 
cells of origin for meningioma is meningothelial cell. Meningiomas are generally seen as 
tumors attached to the dura and compressing the underlying brain. They may also occur as a 
flattened sheath of tumor taking the shape of the underlying bone, so called the en plaque 
meningioma. Rarely, they may arise in a location where dural attachment cannot be 
demonstrated (e.g. intraventricular)  
Site of origin  
Meningiomas can arise from the dura at any site, but most commonly arise from the skull 
vault, skull base (the planum sphenoidale, the sphenoid wing, the petrous ridge, the 
cavernous sinus and perisellar region and the clivus) and at sites of dural reflections (falx 
cerebri, tentorium cerebelli and dura of the adjacent venous sinuses). [6] Other less common 
intracranial sites of origin including the optic-nerve sheath and the choroid plexus 
(intraventricular meningioma). 10% of meningiomas arise in the spine. The distribution of 
meningiomas as seen in Cushing’s series is shown in Table 1. Very rarely, meningiomas 
have also arisen wholly outside the cranio-spinal axis, in the ear and temporal bone, 
mandible, foot, mediastinum, and lung. [6] 
Multiple Meningiomas 
Multiple meningiomas are defined as two or more meningiomas appearing simultaneously or 
sequentially in the same patient. [7] Multiple meningiomas and familial types are rare and 
mostly associated with neurofibromatosis type 2.  
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Etiology 
Trauma, radiation, oncogenic viruses and genetic alterations in the long arm of chromosome 
22 have been implicated in the etiology of meningiomas.[5] In children who have received 
prophylactic irradiation for acute lymphoblastic leukaemia, the incidence of intracranial 
tumours is ten times higher than in the general population (median time to onset 7 years) but 
only 10% of these tumours are meningiomas.  [6] 
Macroscopy 
Meningiomas are rubbery or firm, well-demarcated, sometimes lobulated, rounded masses 
that have a broad dural attachment. They can invade through dura to involve the skull where 
they induce characteristic hyperostosis, even when they are benign. [8] They may infiltrate 
skin and extend to extracranial compartments such as the orbit when malignant. They are 
adherent to, or encase arterial walls, seldom infiltrating them, however, invasion into nearby 
dural venous sinuses is quite common. [1] 
About 1-10% of meningiomas undergo cystic changes [9, 10]  Pathologically, macroscopic cyst 
formation tends to occur most often in meningothelial meningiomas during adulthood, 
whereas the fibroblastic form predominates in infancy [9] 
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WHO GRADING (Table 2) 
In 2007, the World Health Organization revised the classification of Meningiomas. [11] The 
inclusion of brain invasion as a criterion for atypia is the only significant modification to the 
2000 WHO grading scheme. By the likelihood of recurrence and histopathological findings, 
meningiomas are grouped into three grades. 
WHO Grade I  
The grade 1 tumors include Meningothelial, Fibroblastic, Transitional, Psammomatous, 
Angiomatous, Microcystic, Secretory, Lymphoplasmacyte-rich and Metaplastic 
meningiomas.  Grade 1 includes tumor variants that have a low risk of recurrence. [1] The 
histopathological WHO grade 1 tumors generally follow a benign clinical course and have 
only occasional mitotic figures, although pleomorphic nuclei do occur. Various architectural 
patterns are seen within this group. The three commonest architectural patterns are 
meningothelial, fibroblastic, and transitional [1] 
Meningothelial type is the classical variant where the cells form lobules surrounded by thin 
collagenous septae. The tumor cells resemble those of normal arachnoid with oval nuclei.   
In the fibroblastic type spindle shaped cells resembling fibroblasts form parallel and 
interlacing bundles on a matrix abundant in collagen and reticulin.  
The characteristic histological features of cellular whorls and psammoma bodies (round 
calcified bodies) are seen most commonly in the transitional variant. [6]  
Psammomatous meningiomas contain large numbers of psammoma bodies. Angiomatous 
meningiomas are highly vascular. When a small portion of the tumor is histologically studied, 
this variant can be confused with capillary hemangioblastoma  or even a vascular 
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malformation.[1] The Microcystic variant has cells with elongated processes and a loose 
mucinous background, giving an appearance of small cysts. The hallmark of the secretory 
subtype is the presence of focal epithelial differentiation with lumina containing an 
eosinophilic material. These structures are called pseudopsammoma bodies and stain positive 
with carcinoembryonic antigen (CEA). The Lymphoplasmocytic variant has extensive 
chronic inflammatory infilterates with a meningiothelial-like picture in the background. The 
Metaplastic type is a benign meningioma with focal mesenchymal differentiation. 
 WHO Grade II  
Atypical meningiomas are defined as those tumors with increased mitotic activity (four or 
more mitoses per ten high power fields) or three or more of the following five features: 1) 
increased cellularity, 2) small cells with high nuclear/cytoplasmic ratio, 3) prominent 
nucleoli, 4) uninterrupted patternless or sheet like growth and  5) foci of spontaneous or 
geographic necrosis [1] (Table 3)  Two subtypes of WHO grade II meningiomas are 
recognized on the basis of their architectural pattern: Clear-cell and Chordoid meningiomas.  
WHO Grade III 
Grade III meningiomas are subclassified on the basis of their architectural pattern into 
papillary and rhabdoid subtypes. (Table 2) Papillary meningiomas are rare variants and are 
mostly seen in children. They are defined by a perivascular pseudopapillary pattern. 
Rhabdoid meningiomas contain rhabdoid cells that have a specific microscopic appearance 
with eccentric nuclei, abundant globular eosinophilic cytoplasm, and paranuclear inclusions.  
Anaplastic (malignant) meningiomas have obvious malignant cytology, a high mitotic rate 
(20 or more mitotic figures in ten high-power fields), or both. These tumours show a high 
frequency of local and brain invasion, recurrence and metastases. [11] 
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Brain invasion is defined histologically as islands of neoplastic cells that have invaded 
through the pia to involve underlying cortical tissue, commonly producing a gliotic reaction. 
Brain invasion is now one of the criteria used for grading tumours in the WHO 2007 
classification, [11]  because brain invasion is associated with subtotal resection and a higher 
rate of recurrence. 
Recurrence rates 
  Atypical and anaplastic meningiomas reportedly have higher incidence of recurrence rates, 
38%  and 78% respectively, within 5 years after complete surgical removal, compared to 3 
%- 7 % recurrence rates seen for typical meningiomas in old literature. [2] The 5-year rate for 
recurrence of symptoms (regardless of the method of treatment) was 18.2% for those with 
benign tumors and 27.5% for those with malignant tumors. [12]  Recurrence rates were 14.8% 
for benign meningiomas, 66.7% for atypical meningiomas and 100% for malignant 
meningiomas according to study by Tyagi et al. [13]  
Simpson in 1957, [61] classified rate of recurrence based on extent of tumor resection. 
Simpson's Grade I removal is macroscopically complete, with excision of the dural 
attachment of the tumor and any abnormal bone. Grade II is the macroscopically complete 
removal of the tumor and its visible extensions, with coagulation of its dural attachment. 
Grade III is the macroscopically complete removal of the intradural tumor without resection 
or coagulation of its dural attachment or extradural extensions. Grade IV is a partial removal 
of the tumor, leaving the intradural portion of the tumor in place. Grade V is simple 
decompression of the tumor with or without a biopsy. 
In Simpson`s series of 265 meningiomas, he recorded an overall recurrence rate of 21%. The 
recurrence rates were 9% for grade I excision, 19% following grade II excision, 29% 
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following grade III excision and 44% following grade IV excision. Based on Simpson`s 
Grading, subsequent studies have shown similar rates of recurrence, depending on the extent 
of surgical resection.  Mohammed et al [62] who followed up 25 cases of meningiomas for a 
period of 10 years found the recurrence rates to be 8% following grade I excision, 15% 
following grade II and grade III excisions, 29% recurrence following grade IV and 33% 
following grade V excision.  Chan et al [10] found the recurrence rates to be 11% for grade I, 
22% for grade II, 28% for grade III, 33% following grade IV excision and a 100% recurrence 
rate following grade V excision. These studies proved that the extent of tumor resection was 
the single most important factor associated with tumor recurrence and that the extent of 
excision in turn depended on the location of tumor. The convexity tumors had higher rates of 
complete resection in comparison to skull base tumors.  
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Growth Potential of Meningiomas as assessed by various labeling indices 
The growth potential of meningiomas is variable, some remain unchanged in size for a long 
time, whereas others grow rapidly. [14] 
Bromodeoxyuridine 
 Bromodeoxyuridine (BrdU) can detect antigens expressed during the S phase of cell division. 
Histopathological studies using BrdU labeling index (BrdU LI) require intravenous injection 
of BrdU prior to surgery or incubation of cultured tumor cells with BrdU.  Several studies 
have shown that BrdU LI of recurrent tumors was significantly higher than that of the non-
recurrent meningiomas. [14, 15]  However, it is inappropriate for retrospective studies since it 
requires intravenous BrdU injection prior to surgery or incubation of cultured cells with 
BrdU. 
Ki-67 
The Ki-67 protein is a marker for cell proliferation. [16] During interphase, the Ki-67 antigen 
can be exclusively detected within the cell nucleus, whereas in mitosis most of the protein is 
relocated to the surface of the chromosomes. Ki-67 protein is present during all active phases 
of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells (G0). Ki-67 is an 
excellent marker to determine the growth fraction of a given cell population. Cell kinetic 
studies using BrdU LI or Ki-67 staining index reliably predict the speed of growth in various 
tumors. [14, 15]    Shibuya et al [17]  showed that there was a correlation between Ki-67 and WHO 
grade of the tumor.  They examined 44 benign and 8 malignant meningiomas and reported 
mean Ki-67 indices to be 1.45% to 7.2% respectively.  They also showed a correlation 
between Ki-67 and bromodeoxyuridine labeling index (BrdU) 
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MIB-1 LABELING INDEX (MIB-1LI) 
MIB-1 (antibody to Ki-67) is believed to be the most reliable marker for proliferation in 
meningiomas. [6] It reacts with nuclear antigen expressed in the cell cycle of G1, G2 and M 
phases of cell division. 
Correlation with WHO grade: Numerous studies have shown that the MIB-1 LI for atypical 
and malignant meningiomas are higher than in those without atypia. [18, 19, 20]  Abramovich 
and Prayson [20]  in their study of 90 cases of meningiomas reported that the mean MIB-1LIs 
for the benign, atypical and malignant groups were 1.0% (range, 0 to 5.5%), 5.5% (range, 0.1 
to 32.5%) and 12.0% (range, 0.3 to 32.5%) respectively. Differences in the mean MIB-1LI 
between groups were statistically significant, with p values of <.0001 (benign vs. atypical) 
and .0012 (atypical vs. malignant).  However, the mean MIB-1LIs for recurrent versus 
nonrecurring tumors were not significantly different [7.1% versus 3.8%] (p=0.32).  Their 
study had 32 recurrent and 27 non recurrent meningiomas. The mean MIB-1LI for patients 
who were alive with or without tumor was significantly lower (6.2%) compared with those 
who died (14.2%) and concluded that the mean MIB-1LI discriminated between benign, 
aggressive and malignant meningiomas. They also concluded that the interpretation of an 
individual MIB-1LI in a given tumor has to be done with caution, as there was an overlap 
between MIB-1LI ranges among different groups. 
 The cut-off for MIB-1LI that has maximum validity in correlation with the histological grade 
was different according to different authors.  Ming-Tak et al, [21] in their prospective study, 
showed that, 30 of 31 patients (97%) with a MIB-1LI > 10 had recurrence of meningioma in 
the 10 year follow up period and of this 71% of them recurred within 5 years.  Among the 52 
patients with MIB-1LI < 10, there was no recurrence was seen in 10 years. The MIB-1LI for 
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the entire group studied ranged from 0.4 to 33.5 (mean LI, 8.4). They therefore recommend a 
cut-off of 10 for MIB-1LI to differentiate between benign and atypical meningiomas.  
A retrospective study by Devaprasath et al, [22] of all atypical and malignant meningiomas 
diagnosed at our center between January 1995 and June 2000, showed that the MIB-1LI has 
the highest validity in the diagnosis of atypia in meningiomas at a threshold level of 7%. 
Meningiomas with MIB-1LI >7% were found to have statistically significant correlations 
with an increased mitotic index (>4 / 10 HPF), uninterrupted patternless or sheet-like growth, 
increased cellularity and small cells with a high nuclear:cytoplasmic ratio, all of which are 
WHO criteria for the diagnosis of atypia [22] 
Age and gender correlates of MIB-1LI   
Matsuno et al [23] observed that the mean MIB-1LI for patients less than 40 years of age was 
7.5% as compared to 2.9% for patients more than 40 years of age. This was because of a 
higher incidence of atypical meningiomas in the pediatric population. The recurrence rates 
for meningiomas were the same as in adult meningiomas.  In the same study they also found 
that the mean MIB-1LI of the 50 male patients with meningioma was 5.5%, whereas that of 
77 female patients was 2.7%.  These age and sex related differences in MIB-1LI were 
statistically significant.  However, Sandberg et al [24] found that as in adult tumors,  higher 
MIB-1LI correlated with pathological atypia in childhood meningiomas also. They observed 
a statistically significant difference between the median MIB-1LI for tumors with atypical or 
malignant features (median, 12.3%; range, 7.0–31.6%) and that for tumors without  atypia 
(median, 7.0%; range, 1.2–12.6%; P , 0.02) in children. 
In summary, various studies have pointed out a statistically significant correlation between a 
high MIB-1LI value and the aggressive nature of the meningioma [18, 19, 20] as well as with 
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higher recurrence rates. [19] There have been studies showing higher incidence of atypical 
meningiomas and hence a higher range of MIB-1LI values among pediatric age group. [19, 23] 
The study from our institution showed that a cut-off value of 7% for MIB-1LI had highest 
validity in diagnosis of atypical meningiomas.[22] 
 
Although the study of proliferation rates is valuable in planning treatment, these can be 
applied only after surgery. Clinicoradiological findings that help predict the growth potential 
or biological behavior of meningiomas, before surgical treatment would be beneficial for 
appropriate planning of surgery and predicting outcomes.  
 
Natural history of  incidentally diagnosed meningiomas 
Advances in neuroimaging (computed tomography and magnetic resonance imaging) have 
led to the increased identification of patients with incidental meningiomas. There is little 
information on the natural history of these tumors, particularly since they are slow growing. 
It is unclear whether the growth potential increases after the tumor reaches a certain size or 
whether there is any relationship with the age or sex of the patient or the follow-up time.  
Nakamura et al [25]   in a retrospective review of 41 patients with incidentally detected 
meningiomas studied the absolute and relative growth rate and tumor doubling time of these 
tumors without treatment. The diagnosis of meningioma was made on the basis of the 
radiological appearance of the tumor and growth rates measured on annual or six monthly 
follow up imaging. Only 6 of their 41 (14.6%) patients recruited symptoms related to the 
tumor during the study period and had to be operated. They found that, growth rates varied 
from 0.03 – 2.6 cubic centimeters a year and the majority (66%) had growth rates less than 1 
cubic centimeter/year. Annual growth rates tended to be higher and tumor doubling times 
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shorter in younger patients. They did not find any correlation with the initial tumor size and 
tumor doubling time.  In another study, Niiro et al [26] measured the annual absolute growth 
rates in 37 patients with asymptomatic meningiomas and found that tumor growth occurred in 
14 patients and  was associated with age and tumor size. The majority showed no growth in 
their tumors over a follow up period of 41 months.  
Summarizing, the assessment of the exact growth rate of benign brain tumors is difficult, and 
several different methods for tumor growth measurement have been used.   As seen in the 
above mentioned studies, although the majority (60-65%) of patients with incidental 
meningiomas show no growth, 30-35% of these tumors do grow and radiological prediction 
of growth potential may help in counseling these patients an deciding and appropriate 
management, that is, follow up, surgery or radiosurgery. 
 
 
 
 
 
 
 
 
 
 
14 
 
Radiology  
Plain X-ray of skull  
On a plain X-ray of the skull, the changes that are associated with meningiomas are bone 
erosion, hyperostosis, tumor calcification and expanded paranasal sinuses (seen in certain 
anterior basal tumors). Presence of calcification is associated with benign meningiomas. [4]  
CT scan 
Plain and contrast computed tomography detects 85% and 95% of intracranial meningiomas 
respectively. CT scan usually demonstrates a hypo or isodense mass with intense 
enhancement with contrast.  Plain CT scans show a sharply circumscribed round or smoothly 
lobulated mass that abutts a dural surface, usually at an obtuse angle, with buckling of the 
underlying cortex in some cases. Approximately 75% are hyperdense relative to adjacent 
brain. Intratumoral hemorrhage is uncommon in meningiomas. In a series of 313 
meningiomas studied by Cushing and Eisenhardt [4] and 280 meningiomas studied by Horsley 
and Olivecrona, [4] there were no cases of intratumoral bleed. 
CT and Bone involvement 
Abnormalities of bone are frequently encountered in meningiomas. Cushing’s series had 25% 
of cases showing hyperostosis.[4] Diagnosis of hyperostosis can be made easily with 
computerized tomography and magnetic resonance imaging. Different types of bony 
reactions were encountered in Cushing and Eisenhardt`s series namely, bone destruction, 
extensive hyperostosis and endostosis, which is a process of abnormal bone formation in 
which ossification takes place within the cartilage. In the study by Bikmaz et al, [8] on 67 
sphenoid wing meningiomas, there were 17 cases with bone hyperostosis and 
histopathological evaluation of bone specimens in 14 cases, revealed no histological evidence 
15 
 
of malignancy. They had achieved a total removal in 14 cases (82.3%), with only one 
recurrence (7.1%) over a mean follow-up period of 36 months (range 5–72 months) 
suggesting that bony changes in meningioma is not indicative of its malignant potential.     
Theories of hyperostosis:   
The association of hyperostosis with meningiomas was first described by Brissaud and 
Lereboullet in 1903. [8] Hyperostosis results from skull trauma and the tumor is secondary to 
irritation of the dura by the bony growth. Slight movements of the sagittal suture and bregma, 
inducing a stimulatory effect on cells of pachymeninges, explains increased frequency of 
hyperostosing meningiomas in the parasagittal area. [4]  Vasogenic theory states that enhanced 
circulation in the bone, secondary to presence of meningiomas is responsible for 
hyperostosis.  The other theory for hyperostosis is that tumor cells themselves can produce 
fibroblasts, osteoblasts and osteoclasts [4] 
Summarizing, hyperostosis has not shown to be one of the factors which can predict the 
aggressive behavior or recurrence rates in meningiomas.  
CT and tumor calcification 
Calcification is seen in 20-25% of the tumors. [28] Calcification can be focal or diffuse. They 
can occur in patterns like psammomatous (sand like), sunburst, or globular and even rim like 
pattern.  Presence of calcification is considered a feature of benign meningiomas [29] 
MRI findings of meningioma 
T1W and T2W images 
Regardless of the histological type, most meningiomas are iso- or slightly hypointense 
relative to cortex on T1 weighted studies, although signal on T2 weighted studies is variable. 
Elster et al [30] correlated the MRI appearance of 40 biopsy proven meningiomas with 
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histological pattern. They observed that meningiomas that are markedly hypointense on T2 
weighted images were composed predominantly of fibroblastic or transitional elements. 
Syncytial meningiomas composed of sheets of contiguous cells and rather sparse interstitium 
had higher signal on T2 weighted images. Angiomatous meningiomas with dilated blood 
vessels, vacuoles and high cellularity, were also found to be hyperintense on T2 weighted 
images. [30] This correlation of signal intensity with histologic subtype was highly significant 
statistically (P < .001, in K-W analysis of variance) 
 Chen et al [31] made similar observations in correlation of T2W images with histological type 
of the tumor.  MRI is also helpful in predicting the dural venous sinus involvement by the 
tumor.  Zee et al [9]  showed a 90% positive predictive value in detecting dural venous sinus 
involvement by meningiomas on T1W images. 
FLAIR sequences 
In the study by Gasperetto et al [32]  on 78 patients with meningiomas, in the FLAIR sequence 
69%  of tumors had high signal, 22 % had intermediate signal and 9 % had low signal. The 
lesions were heterogenous on FLAIR sequences in 64% of cases.  In a prospective study on 
21 patients with meningiomas,  Yrjana et al [33] reported that peritumoral edema was most 
clearly seen in FLAIR images as areas of high signal around the tumor.  They studied the 
correlation between MRI characteristics and various tissue parameters of meningiomas 
namely consistency, bleeding at surgery, progesterone receptor expression, micro vessel 
density and collagen content of the tumor. They found a positive correlation between 
progesterone receptor expression and relative intensity of tumor on FLAIR images. A 
negative correlation was found between the previously mentioned intensity and grade of 
collagen content in meningioma tissue. Surgical bleeding and blood loss correlated 
moderately with relative intensity on FLAIR images. Time to maximum enhancement derived 
from dynamic T1-weighted imaging predicts microvascular density of meningioma tissue. 
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They concluded that MR imaging cannot give definitive answers to questions of consistency, 
vascularity, and histologic parameters of meningiomas but may still give us an idea of the 
factors that should be taken into account when planning surgery of meningioma.   
 
Contrast  
MRI with intravenous gadolinium enhancement provides valuable additional information in the 
radiological evaluation of meningiomas. Meningiomas show a uniform enhancement on intravenous 
administration of gadolinium compound (Gd-DTPA).  Enhancement pattern in meningiomas may be 
homogenous or heterogenous.  In the study done on MRI findings of 78 patients with meningiomas, 
by Gasperetto et al [32]  following contrast administration, 83% had accentuated enhancement and 17% 
had moderate enhancement.  They also noted that the contrast enhancement was heterogenous in 64% 
of cases.  Dural tail sign was seen in 59% and 29% of the tumors showed evidence of bone infiltration 
in their study. 
Dural tail 
In 1989, Wilms [34] first described meningeal enhancement surrounding meningiomas on T1 
weighted MRI scans obtained with gadolinium administration. This finding has been 
described as ‘dural tail sign.’ or “flare sign”. Nakau et al [35] did a pathological study on the 
dura mater resected from the margins of meningiomas exhibiting the ‘flare sign’ and tried to 
assess the optimal width of dura mater that needs to be resected from tumor margin. They 
demonstrated tumor cells in dural tail, but were not able to point out the exact extent of dural 
infiltration beyond the tumor margins. They suggested a wide excision of dura mater that 
exhibited the flare sign.  
 
 
Consistency 
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Yamaguchi et al [36] studied the relationship of MRI findings with the consistency of the 
tumor. They found, in their study of 50 cases that there was no significant relationship 
between the T1W images and the consistency of the tumors. T2W and proton density (PD) 
images on the other hand had statistically significant relationship with the tumor consistency, 
revealing soft meningiomas as hyperintense in 80.8% of cases. Hypointensity on T1 with 
hyperintensity on T2 and PD images always revealed a soft tumor. Isointensity or 
hypointensity on T2 or PD indicated a hard tumor. If the image findings were suggestive of a 
`hard` meningioma, a preoperative embolization was considered beneficial to induce necrosis 
and convert it to a `soft` meningioma, which was easier to excise. [36] Cystic degeneration 
occurs in meningiomas and these are seen as hypointense lesions in the T1W images. 
Chen et al [31] reported a study on 54 patients, where they predicted the gross and microscopic 
tumor characteristics such as vascularity, consistency, venous sinus involvement, presence of 
cystic changes and histopathological features using MRI.  They showed that hyperintensity 
on T2W images, was useful in predicting hypervascularity. They also found that soft tumors 
were hyperintense on T2w images, as was reported in other studies. [30] They did not find any 
correlation between the peritumoral edema and vascularity or histological type of the tumor.  
Vascularity  
Previous studies with CT [37] scan  had showed no relationship between the degree of contrast 
enhancement and vascularity of the tumor. Similarly there was no correlation between 
gadolinium enhancement on MRI and the vascularity or histological type of meningioma.[31] 
The other observation in the study was that cystic meningiomas were best identified with 
T1W images. They appear hypointense to gray matter in T1W and hyperintense to gray in 
T2W images. Flow voids on MRI are seen secondary to pulsatile and turbulent high velocity 
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blood flow, [31] and are seen on T1W images in the presence of large intratumoral blood 
vessels. [37] 
Summarizing, intracranial meningiomas are generally found to have heterogenous low signal 
on T1W MR images and heterogenous intensities on T2W and FLAIR images, with intense 
enhancement following contrast administration.  Presence of a low T2W signal suggests a 
hard tumor consistency probably, due to a high collagen content.  
Dural enhancement around the meningioma (dural tail sign) warrants a wider excision of dura 
mater. MRV helps in pre operative assessment of venous sinus involvement and venous 
drainage of the tumor. 
Peritumoral edema 
There have been studies that correlated peritumoral brain edema (PTBE) with various clinico 
pathological parameters of meningiomas. [28, 31, 36-50]   
Etiology of peritumoral edema 
The exact etiology of peritumoral brain edema associated with meningiomas is not well 
understood.[50] Factors that may affect the occurrence of peritumoral edema include tumor 
size, histological subtypes, vascularity,  levels of Vascular Endothelial Growth Factor 
(VEGF) and sex hormone in the tumor, venous stasis, and brain invasion [42, 13]  
Peritumoral edema and Size 
 Lee et al [47]  correlated the volume of the tumor with the volume of the peritumoral edema.  
The study used edema index described previously [44] and was calculated as follows:   
 Edema index (EI) = V (edema+tumor)/Vtumor, where V= volume; EI was equal to 1 when edema 
was absent. The volume of tumor and edema was measured from the MR image. The 
maximal perpendicular diameters (radii a and b) of the tumor and the edema in the axial MR 
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sections were measured. Coronal diameters of the tumor and the edema were approximated 
by using the number of axial images showing tumor tissue and edema multiplied by the slice 
thickness. (radius c) The volume was calculated using the formula V = 4/3πabc.  
The Edema Index was higher in the larger tumors presumably because they cause more 
brain compression, leading to ischemia and secondary brain edema. According to their study, 
large tumor volume was closely related to increased pial cortical blood supply that is 
considered to be a critical factor in the development of PTBE. Although some studies noted 
no correlation between meningioma size and the incidence of peritumoral edema, [48, 49] a 
number of authors agree that there is a significantly higher incidence of PTBE with large 
meningiomas in comparison with  small ones [44, 45, 51] 
Vascular Endothelial Growth Factor and edema 
Ding et al [46] examined the protein and gene expression of VEGF in 37 meningiomas and 
peritumoral brain areas.  Immunohistochemical staining and immunoblotting were performed 
to detect the expression of VEGF protein in the tumor and edema. Reverse-transcriptase 
polymerase chain reaction (RT-PCR) was used to analyze the presence and quantity of VEGF 
mRNA. The extent of PTBE was estimated as an edema index (EI) based on preoperative 
magnetic resonance imaging (similar to the method described by Lee et al. [47]  The 
expression of both protein and mRNA in the tumor had a significant correlation with EI and 
the mRNA was not seen in areas of perilesional edema, suggesting that VEGF 
macromolecules are secreted by the tumor tissue and enter peritumoral normal brain tissue to 
induce edema. They did not correlate the levels of VEGF to the grade of the edema. 
Location and proximity to venous sinus 
Previous reports on the relationship between tumor location and PTBE have not demonstrated 
consistent results. Convexity, [31, 49, 50] parasagittal, [49, 50] falx [31] and  sphenoid ridge [31] are 
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sites where tumor produce more PTBE.   The reasons for this discrepancy are thought to be 
differences in the classification of tumor attachment, especially in older research performed 
using computed tomography and in the evaluation of edema (edema index or EI).[43]   
However, several authors agreed that tumors  on  the tentorium and posterior fossa were 
associated with less peritumoral edema [49, 50] 
Although,  some studies on meningiomas have associated edema with proximity to venous 
sinuses, Bitzer et al, [44] did not find increased edema in the   meningiomas that obstructed 
venous drainage of their total number of 134 tumors.  
 
Correlation of edema with histological grade and histological subtype: 
Lee et al [47] studied 79 meningiomas, 71 Grade I  and 8 Grade II/III  and found a significantly 
higher incidence of PTBE in the grade II/III group (p = 0.004). However, despite being 
benign the ‘Angiomatous’ variant had marked PTBE. While the atypical and malignant 
subtypes correlated with PTBE in the univariate analyses they did not reach significance in 
the multivariate analyses, when the pial-cortical arterial supply, male sex and hyperintensity 
on T2WI were the other factors included in the analysis.  
Ide et al, [42] found a significant correlation of both the MIB-1LI and tumor size with the 
extent of edema. They studied MIB-1LI in 57 histologically proven intracranial meningiomas 
along with radiological factors that could influence development of peritumoral brain edema. 
Their study had 54 benign and only 2 atypical and 1 anaplastic meningiomas. The extent of 
peritumoral brain edema was determined using preoperative magnetic resonance imaging and 
was classified as Grade 0, 1, or 2 in order of increasing severity.  Grade 0 represented no 
brain parenchymal edema or a small halo around the tumor, Grade 1 represented edema 
extending along white matter tracts for varying distances without involving the entire 
hemisphere and Grade 2 represented holohemispheric or near-holohemispheric edema. The 
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MIB-1LIs of the 57 cases ranged from 0.06-6.8% (median, 0.8%). There were 26 grade 0, 20 
grade 1, and 11 grade 2 edema cases. The MIB-1LI rose in order of increasing edema 
severity. There was a statistically significant correlation between the MIB-1LI and the extent 
of brain edema (p<0.0001) and also between the tumor size and the extent of brain edema 
(P=0.001).   Atypical/anaplastic meningiomas were associated with peritumoral brain edema 
more often than any other subtype (P<0.005).  However, it was not clear as to how a 
statistical significance was seen, with only two cases of atypical and only one case of 
anaplastic meningioma in their study Moreover, the MIB-1LI of the two atypical 
meningiomas were 2.1% and 3.4% and the MIB-1LI of malignant meningioma was 6.68% 
which was low in comparison with the cut off of 7% used in our study. They also found that 
the meningothelial subtypes and one transitional meningioma had MIB-1LI higher than the 
lowest MIB-1LI of the atypical meningiomas, raising doubts regarding the accuracy of these 
MIB-1LI.  
Some studies in the past have linked peritumoral edema with malignancy. [28, 39, 40]  On the 
other hand, there were some other studies like that by Younis et al, [41]  where one third of 
patients with malignant meningiomas, had no cerebral edema, suggesting that the presence of 
edema does not necessarily indicate a malignant lesion and absence of edema does not 
necessarily exclude malignancy. 
 
 Peritumoral edema association with brain invasion: 
Tamiya et al [43] retrospectively studied radiological factors on MRI causing peritumoral 
edema in 125 meningiomas with 121 benign, no atypical and 4 malignant tumors. The factors 
studied were histology, tumor size, location, brain-tumor interface, signal intensity on T2-
weighted scans, contrast enhancement, and cyst formation, as well as tumor vascularity and 
blood supply (as observed in digital subtraction angiography studies). They did not do a 
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MIB-1LI or WHO grading.  A relationship between the tumor size and the volume of PTBE 
(measured using the edema index EI= Volume of tumor+edema/ volume of tumor) was 
observed. Convexity and middle fossa meningiomas demonstrated the highest mean edema 
indices. Meningothelial, Anaplastic, Microcystic, and Angiomatous subtypes exhibited higher 
edema indices than did other types. 
 Multivariate analysis demonstrated two significant radiological factors: cortical penetration 
(as defined by the disappearance of the arachnoid layer on magnetic resonance imaging 
scans) and vascular supply from the pial-cortical arteries as observed on angiograms.   
 Mantle et al [38]  had another grading system for the peritumoral edema for meningiomas, as 
seen on the non-contrast CT scan. It was expressed as the thickness of the low attenuation 
area (7-25 Hounsfield units), measured to the nearest centimeter from the outer edge of the 
tumor to the outer edge of the parenchyma on the best axial slice (that which shows the 
largest cross sectional area of the tumor).  The edema grading scale was validated by 
correlation with the actual volume of edema determined by digitizing 29 CT scans by using 
public domain software. The edema volume and tumor volume was calculated in cubic 
centimeters.  According to this study, the chance of brain invasion increased by 20% for each 
centimeter of edema (p = 0.0001; 124 cases). The presence of brain invasion seen on 
histopathology in 42 cases was predictive of recurrence after complete resection with an 
accuracy of 83%, a sensitivity of 89%, and a specificity of 82%.  
In  the study by Fransesco et al, [52]  the tumor-brain interface on  preoperative CT scans  was 
analyzed  and the perifocal effects on brain tissue surrounding meningiomas were classified 
into three groups: no perifocal reaction, a perifocal halo-like hypodensity, and a hemispheric 
finger-like hypodensity.  Of the 52 patients in the study, 13 had no reaction around the 
meningioma on the CT scan, 39 had zones of diminished density surrounding the lesions; 21 
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had halo-like perifocal hypodense areas confined to the vicinities of the tumors.  Of these 18 
patients showed finger-like hemispheric areas that spread into the white matter.  
 
Summary of peritumoral edema 
The exact etiology of peritumoral edema in meningioma is not known, but factors such as 
size, proximity to sinuses, sex hormone receptors and brain invasion have been implicated. 
Vascular Endothelial Growth Factor has been shown to be secreted by meningiomas and the 
degree of its expression has been correlated with the edema grade. The correlation of 
peritumoral brain edema with WHO grade of the tumor is inconsistent with a few studies 
correlating higher grades of edema with higher WHO grades. On the contrary severe edema 
has been seen in certain benign variants as well. Recently Zhang et al [53] showed that the 
difference in the perfusion MR imaging findings of  peritumoral brain edema in benign and  
malignant tumors, may find its application in predicting the histological grade of the tumor. 
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Interface between Meningioma and the Brain on MRI 
A few studies in the past have studied the tumor-brain interface of meningioma. [41, 52, 54, 55, 56]  
Microscopy 
Nakasu et al [55] studied the microscopic anatomy of tumor-brain interface of 50 meningiomas 
and found that the type 4 collagen which was present in the basement membrane forming the 
demarcation between the tumor and brain of benign meningiomas, was lacking in the atypical 
and anaplastic variants.  In two benign meningiomas that looked like an invasive growth, 
Col4 staining was seen above the brain and pia mater-like structure covered the tumor surface 
in both cases. Statistical significance of this finding however was not calculated. 
Macroscopy 
Nakasu et al [56] in a descriptive  study, based on 27 non-operated supratentorial meningiomas 
from autopsies, classified  the tumor-brain interface into four types namely, smooth, lobular, 
finger-like expansion, and invasive.   
Radiology 
An indistinct tumor-brain interface on CT and MR imaging may indicate brain invasion and 
has been associated with aggressiveness of the tumors. [41]   Invasion of the brain is difficult to 
assess radiologically because the invasion may be just microscopic. The signal intensities 
from the tumor are sometimes very similar to brain tissue; thereby the tumor-brain interface 
may be difficult to interpret. This difficulty can be overcome by administrating intravenous 
contrast. [55] 
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Nakasu, et al [55] studied the MRI findings of the tumor-brain interface.   The thick 
collagenous connective tissue, which was seen around four tumors, was shown as a low 
signal intensity rim on both T1 and T2-weighted images. A rim of low signal intensity on a 
T1-weighted image and high signal intensity on a T2-weighted image most likely represented 
a cerebrospinal fluid space: this finding was seen around eight tumors. No distinct rim could 
be identified in five tumors, two of which grew invasively into the brain, suggesting that 
presence of a distinct rim of CSF around the meningioma indicates a histologically benign 
meningioma and its disruption suggests brain invasion. 
Intra-operative assessment of tumor-brain interface 
On classifying the tumor-brain interface at surgery in 52 (48 benign, 0 atypical and 4 
anaplastic ) meningiomas, Francesco et al,[57] found three kinds of interfaces namely smooth, 
transitional and invasive types. They correlated these intraoperative findings with the 
interface assessed on CT images which was again classified to three types, the first with no 
perifocal effects on brain had 13 cases, the second with perifocal halo like hypodensity had 
21 and the third group characterized by finger like projections into the hemisphere had 18 
patients.  In all 18 cases of invasive types (100%) and 3 of the 21 transitional types (14.3%), 
they observed disruption of cerebral cortex intraoperatively. All the invasive type tumors 
correlated with finger like edema seen in pre operative CT scan. There were no cases of 
cortical disruption noted in ‘smooth tumors’.  Based on their findings they concluded that, 
prediction of the microsurgical effort needed for surgery of meningiomas can be made with 
the findings of type of hypodensity around the tumor on CT scan and stated that cerebral 
cortex penetration occurs in every case of invasive microsurgical-type meningioma and in a 
low percentage of  (14.3%) transitional type meningiomas.  However, it is clear from their 
observations that  there is no correlation of the type of tumor-brain interface found at surgery 
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and the histological grade of the tumors, as there were only 4 WHO II/III  tumors in the study  
and  there were 18 cases of  ‘invasive’ and 21 cases of ‘transitional’ type of tumor-brain 
interface that were identified.  There was a statistically significant correlation  of ambiguous 
tumor-brain interface with MIB-1LI  in the study by Hashiba et al [3] Tumors with distinct 
peritumoral rim of CSF had MIB-1LI of 2.27% in comparison to those with indistinct tumor 
brain interface with a MIB-1LI of 3.8%  (p< 0.05). 
 Summarizing, a few studies[55, 57]  have indicated that disruption of the tumor-brain interface 
is associated with brain invasion, pointing to a higher histological grade.   
Shape of the tumor 
There are a number of studies that have correlated the shape of meningiomas to their 
biological behavior. [39, 54] The shapes of meningiomas have been described as round 
(smoothly curved surfaces pushing against the brain), lobulated (nodular surfaces pushing 
against the brain) and mushrooming meningiomas. [39] Mushrooming tumors were defined as 
having a prominent pannus extending over the cerebral surface from the globoid portion of 
the tumor [39] 
Shape and tumor recurrence: 
New et al, [39]  first described  the ‘mushrooming’ shape of meningiomas as identified on the 
CT images of the brain.   Features that could be correlated with malignancy were assessed by 
reviewing the microscopic slides of 167 meningiomas. In cases with three or more 
recurrences, the number of mitoses counted under high power was higher than in those 
meningiomas showing clinically benign behavior. The radiologic and histologic features of 
seven meningiomas showing malignant clinical behavior and/or malignant histologic features 
were also evaluated and correlated. “Mushrooming," occurred in five of the seven malignant 
cases and was absent in the benign meningiomas that were reviewed 
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In a prospective study, [58] 101 meningiomas (1 anaplastic, 8 atypical and 92 benign) were 
followed up for at least 5 years after surgery. Recurrent meningiomas occurred in 17 patients. 
The study had 3 mushrooming, 22 lobulated and 74 round tumors. The shape of the tumor 
had a significant association with recurrence. All 3 tumors with mushrooming shapes (100%), 
7 of the 22 lobulated tumors (31.8%) and 5 of the 74(6%) round tumors recurred. There was 
no significant difference in extent of excision in these three groups. These findings were 
corroborated  by Idan et al, [59] who studied 201 patients with meningiomas where shape of 
the tumor, edema, calcification and vascularity were correlated studied  to tumor recurrence 
and WHO grading. The tumor shape was categorized as round, lobulated, and mushrooming 
as in the previous study by Nakasu et al. [58] They found that tumor shape was statistically 
related to recurrence.  Four of the six (66.6%) mushrooming tumors, 7 of the 28 (25.0%) 
lobulated tumors and only 5 of the 103 (4.8%) round tumors recurred. Time to recurrence 
was significantly longer for round tumors (105 months) and shorter for lobulated (87.5 
months) and shortest for tumors with mushrooming. Furthermore, the four mushrooming 
tumors that recurred belonged to the WHO grade II/III group. 
 
Quantification of irregularity of shape 
   Nawashiro et al [60] suggested quantification of irregularity of shape using an index called 
irregularity index (IR) defined as a ratio between the square of the perimeter and the area of 
the tumor. This index is low in circular tumors and higher in complex or irregular shaped 
tumors. They found a significant difference (p = 0.001) in the IR between benign 
meningiomas and atypical or anaplastic meningiomas. They also found a significant 
correlation between the IR and proliferative potential of the tumor as estimated based on 
MIB-1LI immunohistochemical findings. 
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Attempt at preoperative radiological score  in a previous study  
Hashiba et al [3]  in a retrospective study with 90 cases of intracranial meningiomas compared 
preoperative MRI and CT findings with MIB-LI of the tumor.  All the radiological images 
were studied by the first author and at least one of the 6 other authors. The radiological 
parameters studied by them were; location of the tumor, signal intensity, tumor size, contrast 
enhancement, perilesional edema, shape of tumor, tumor-brain interface and presence of 
calcification (as seen on CT scan).   
The correlation between radiological parameters and high MIB-1LI was determined 
statistically and those with a positive correlation were later used for calculation of a 
preoperative radiological score. Only three factors had a positive correlation with the high 
MIB-1 index namely; the peritumoral brain edema, tumor-brain interface and irregular shape.  
Irregularly shaped tumor had a mean MIB-1LI of 4.6% and smooth shaped ones a mean 
MIB-1LI of 1.8% (p= 0.0005).  Tumors with edema had a mean MIB-1LI of 3.8% and those 
without edema had a mean MIB-1LI of 2% (p< 0.05). Tumors with a distinct peritumoral rim 
of CSF had a MIB-1LI of 2.3% in comparison to those with an indistinct tumor brain 
interface with a MIB-1LI of 3.8% (p< 0.05). They thus devised a scoring system with these 
three radiological parameters as follows: smooth tumors = 0, irregular shaped tumors =1; 
Peritumoral edema present =1, absent = 0; Tumor-brain interface: indistinct = 1, distinct = 0. 
The total radiological score for each tumor was calculated. They had 32, 18, 19 and 21 
patients with total radiological scores of 0, 1, 2 and 3 respectively. Their corresponding 
median MIB-1LI values were 1.3, 1.5, 1.6 and 2.7% indicating that there was steady increase 
in the mean MIB-1LI value with an increase in the total radiological score. Although the 
authors agreed to have differences in the scoring amongst themselves, the details of 
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individual scores by the observers and the inter observer variation was not available in the 
article. They did not classify the tumors into WHO Grades. 
 
Recurrence rates 
Simpson in 1957, [61] classified rate of recurrence based on extent of tumor resection. 
Simpson's Grade I removal is macroscopically complete, with excision of the dural 
attachment of the tumor and any abnormal bone. Grade II is the macroscopically complete 
removal of the tumor and its visible extensions, with coagulation of its dural attachment. 
Grade III is the macroscopically complete removal of the intradural tumor without resection 
or coagulation of its dural attachment or extradural extensions. Grade IV is a partial removal 
of the tumor, leaving the intradural portion of the tumor in place. Grade V is simple 
decompression of the tumor with or without a biopsy 
In Simpson`s series of 265 meningiomas, he recorded a 21% recurrence rate (55 cases).  The 
recurrence rates were 9% for grade I excision , 19% following grade II excision, 29% 
following grade III excision and 44% following grade IV excision. Based on Simpson`s 
Grading, subsequent studies have shown similar rtes of recurrence, depending on the extent 
of surgical resection.  Mohammed et al [62] who followed up 25 cases of meningiomas for a 
period of 10 years found the recurrence rates to be 8% following grade I excision, 15% 
following grade II and grade III excisions, 29% recurrence following grade IV and 33% 
following grade V excision.  Chan et al [10] found the recurrence rates to be 11% for grade I, 
22% for grade II, 28% for grade III, 33% following grade IV excision and a 100% recurrence 
rate following grade V excision. These studies were depicting that the extent of tumor 
resection was the single most factor associated with tumor recurrence. They also correlated 
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that the degree of tumor resection in turn depended on the location of tumor. The convexity 
tumors had higher rates of complete resection in comparison to skull base tumors.  
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Aim   
To predict the biological behavior of intracranial meningiomas based on the pre-operative 
Magnetic Resonance Imaging findings. 
Objective 
To correlate the MRI findings of intracranial meningiomas, namely, the peritumoral edema, 
tumor-brain interfaces and shape of the tumor with the MIB-1LI of the tumor.  
Hypothesis 
In meningiomas, MRI findings of peritumoral brain edema, ill-defined tumor-brain interface 
and irregular shape, predict an atypical / malignant tumor 
Materials and Methods 
Between January 2003 and June 2007, 373 patients underwent excision of intracranial 
meningiomas at our institution. Of them only 246 had a pre-operative MRI of the brain done 
either in our institute or elsewhere. All the cases had histopathological assessment, including 
immunohistochemistry done at our institute. 188 of the 246 cases were diagnosed to have 
WHO grade I (benign) meningiomas, 52 were diagnosed to have WHO grade II and 6 had 
WHO grade III meningiomas.  They were grouped as Group A (benign) and Group B 
(atypical and malignant together) 
A subset was made by matching every 2 patients from Group A with one patient of Group B, 
to reduce the sample size. The matching was based on the following criteria: 
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1. Age (+/- 5 years) 
2. Gender 
3. Location of the tumor (convexity/base of skull) 
4. Size of the tumor (+/- 1 cm in any direction)  
The subset had 132 patients after matching with patients of benign and malignant 
meningiomas in the ratio of 2:1. Five of these 132 cases were discarded from the study due to 
non-availability of T2W images or poor quality images.  The final number of cases included 
in the study was thus 127.  The list was randomized by arranging the names in alphabetical 
order and was presented in that order to the two neurosurgeons. 
The pre-operative MRI brain of these patients were studied separately by two neurosurgeons 
(VR and AGC) focusing on three parameters namely, perilesional edema, tumor-brain 
interface and shape of the tumor. A score was assigned to each of the parameters as shown in 
Table 4. T2W axial images were used to assess the perilesional edema. The shape of the 
tumor and tumor brain interface was assessed on T2W images and T1w with gadolinium 
images. 
The MIB-1LI of these tumors was assessed by a Neuropathologist (GC).   
Immunohistochemical staining technique using monoclonal antibody to MIB-1 (DAKO Patts, 
Denmark) was performed as detailed in Appendix 1. 
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 The two neurosurgeons were blinded to the MIB-1LI or any other aspects of the clinical and 
histopathological details for the tumor. There was no prior discussion between the two 
neurosurgeons regarding the three MRI parameters that were being assessed. 
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Results 
The study included 127 (86 grade I and 41 grade II/III) intracranial meningiomas in 69 
(54.3%) males and 58(45.7%) females, in the age group 20 – 68 years (mean 46.68; SD 
10.46). 
The MIB-1LI of the tumors ranged from 0.5 to 24% (mean 6.37; SD 5.43). The mean MIB-
1LI was 11.8% for atypical and 3.8% for benign meningiomas, the difference in the two 
groups being statistically significant (p value = 0.0001) (Figure 1).  
Table 5 classifies the tumors based on their MIB-1LI values using 7% as the cut off as 
indicated in our previous study.(22)   Of the 127 cases, 50 had an MIB-1LI of ≥ 7% while 77 
had an MIB-1LI of < 7%. Based on the WHO 2007 grading, of 127 total cases 41 were 
atypical and 86 were benign, since we had chosen them in a ratio of 1:2. The correlation 
between MIB-1LI and histological grade was assessed.  Of the 41 atypical tumors, 36 had a 
MIB-1LI of ≥ 7 and 5 had a MIB-1LI < 7.   From the total of 86 benign tumors, 72 had a 
MIB-1LI of < 7.  It was calculated that MIB-1LI has a sensitivity of 87.8%, specificity of 
83.7%, and positive predictive value of 72% and negative predictive value of 93.5% in 
correlation with histological grade of the tumor.  
The three parameters namely perilesional edema, tumor-brain interface and shape of the 
tumor were recorded independently by two neurosurgeons and a total radiological score 
(minimum score of 0 and maximum score of 3) was assigned to each subject. Appendix 4 
shows the scores assigned to individual cases, for the three MRI parameters by both the 
observers.  
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The scores for each parameter: 
Peritumoral Edema  
Perilesional edema was present in 76 (59.8%) and absent in 51(40.1%) of total cases 
according to Observer 1, in comparison to 89(70.1%) where edema was present and 38 
(29.9%) where it was absent according to Observer 2. Of the 76 cases with edema according 
to Observer 1, 24 were atypical and 52 were benign meningiomas as per the WHO 2007 
grading. Out of the 89 cases in which Observer 2 had detected edema, 30 were atypical and 
59 were benign. (Table 6) 
Thus the sensitivity, specificity, positive predictive value and negative predictive value for 
edema in predicting atypical nature of meningiomas were 58.5%, 39.5%, 31.5% and 66.7% 
according to Observer 1; and 73.1%, 31.4%, 33.7% and 71.1% according to Observer 2. 
(Table 8) 
On considering MIB-1LI of these cases (Table 7), it was seen that of the 50 cases of MIB-
1L1 more than 7, Observer 1 had detected edema in 32 cases and Observer 2 had detected 
edema in 37 cases. In the 77 cases with MIB-1LI less than 7, Observer 1 had stated absence 
of edema in 33 cases while Observer 1 had stated absence of edema in 25 cases.  
 
Thus, according to Observer 1, edema had a sensitivity of 64%, specificity of 42.8%, and 
positive predictive value of 42.1% and negative predictive value of 64.7%. According to 
Observer 2, edema had a sensitivity of 74% and specificity of 32.4%, positive predictive 
value of 41.5% and negative predictive value of 65.7% in identifying a high MIB-1LI. (Table 
7, 8)   
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Among the 50 meningiomas with MIB-1LI ≥ 7%, 31 meningiomas were found to have 
edema as per both observers; 11 to have no edema as per both observers; where as 8 were not 
matching; of these; according to Observer 1, 7 did not have any edema and 1 had edema; 
where as Observer 2 had stated 6 to have edema and 2 to not have edema.  
In the MIB-1LI < 7 % group of 77 meningiomas; 42 were agreed upon to have edema and 23 
to not have edema by the two observers; 12 were not matching; of which according to 
Observer 1, 10 had no edema and 2 had edema; where as Observer 2 found 2 to have no 
edema and 10 to have edema. 
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Tumor Brain Interface  
Ill-defined tumor brain interface was seen in 12 (9.4%) and it was thought to be well defined 
in 115 (90.6%) of the total cases according to Observer 1, in comparison to 42(33.1%) ill-
defined interface and 85 (66.9%) well defined interface for Observer 2.  
Of the 12 tumors that Observer 1 had classified as ill-defined, 7 were atypical and 5 were 
benign meningiomas.  Out of the 43 cases in which Observer 2 had recorded an ill-defined 
tumor-brain interface, 17 were atypical and 25 were benign. (Table 9) 
Thus the sensitivity, specificity, positive predictive value and negative predictive value for 
tumor-brain interface in predicting atypical nature of meningiomas, according to Observer 1 
was 12.2%, 91.9%, 41.7% and 68.7%; while according to Observer 2, it was 41.5%, 70.9%, 
40.5% and 71.7%. (Table 11) 
On considering the MIB-1LI of these cases, it was seen that of the 50 cases of MIB-1L1 ≥7, 
Observer 1 had detected ill-defined interface in 6 cases and Observer 2 had detected ill-
defined interface in 19 cases. Out of 77 cases with MIB-1LI < 7, Observer 1 had detected 
well defined interface in 71 cases and Observer 2 had stated well defined interface in 54 
cases. (Table 10)  
 
Thus the sensitivity, specificity, positive predictive value and negative predictive value for 
tumor-brain interface, according to Observer 1 was 12%, 92.2%, 50.0% and 61.73%; and 
according to Observer 2, it was 38% ,70.1%, 45.2% and 63.3% in predicting a high MIB-1LI. 
( Table 10) 
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Presence of ill-defined brain tumor interface alone in the scan did not correspond to higher 
MIB-1LI in both the observations in statistically significant measures as per Chi square test. 
(p =0.428 in Observer 1, p =0.341 in Observer 2)   
 
Looking into the levels of agreement on picking up ill defined brain tumor interface, out of 
the 50 meningiomas with MIB-1LI ≥7 %, 6 were agreed upon by both observers to have an ill 
defined brain tumor interface and 31 were agreed upon to have a well defined interface. 
However 13 observations were not matching; all of which were document to have well 
defined interface by Observer 1 and an ill defined interface by Observer 2 respectively.  
 
In the group with an MIB-1LI < 7, 5 cases were agreed upon by both the observers to have 
ill-defined tumor-brain interface and 53 were agreed upon to have a well-defined tumor- 
brain interface. In the 19 that were not matching Observer 1 had stated that 18 of them had a 
well-defined interface and only one had ill defined interface; while Observer 2 had marked 
ill-defined interface for 18 and well-defined interface for one case only.  
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Shape of Tumor:  
The tumor shape was classified as irregular in 28 (22.0%) and regular in 99 (78%) of the total 
cases according to Observer 1. According to Observer 2, 55(43.3%) were irregular shaped 
tumors and 75 (56.7%) regular shaped tumors. 
  
Out of the 28 cases which the Observer 1 had recorded irregular shape, 14 were atypical and 
14 were benign meningiomas.  Out of the 55 cases which Observer 2 had recorded irregular 
shape, 24 were atypical and 31 were benign. (Table 12) 
Thus the sensitivity, specificity, positive predictive value and negative predictive value for 
shape of tumor, according to Observer 1 was 34.1%, 83.7%, 50% and 72.7%; while it was 
58.5%, 63.9%, 43.6% and 76.4% according to Observer 2 in predicting atypical nature of 
meningiomas. (Table 14) 
 
On considering the MIB-1LI of these cases, it was seen that of the 50 cases of MIB-1L1 
≥7%, Observer 1 had detected an irregular shaped in 15 cases and Observer 2 had detected an 
irregular shape in 27 cases. Out of 77 cases with MIB-1LI of < 7% Observer 1 had detected 
regular shape in 64 cases and Observer 2 had stated regular shape in 49 cases. (Sensitivity of 
30% and specificity of 83%, positive predictive value of 53.5% and negative predictive value 
of 64.65%). Observer 2 had a sensitivity of 54% and specificity of 63.6%, positive predictive 
value of 49.1% and negative predictive value of 68.1% in correlation with the MIB-1LI. 
(Table 13) 
 
Presence of irregular shape of tumor alone in the scan did not correspond to higher MIB-1LI 
in the observations by Observer 1; in statistically significant measures as per Chi square test; 
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but was found to be significant as per Observer 2. (p = 0.081 in Observer 1, p =0.05 in 
Observer 2)   
 
Analyzing the inter observer agreement on findings of shape of tumor; out of the 50 
meningiomas with MIB-1LI more than 7%; 14 were found to have an irregular shape of 
tumor by both observers, 22 had a regular shape by both observers; while 14 did not match. 
Of the 14 that did not match; 13 were marked to have a regular shape by Observer 1 and only 
one was irregular shaped; where as Observer 2 found only one to have a regular shape and 13 
were irregular.  
 
In the group of 77 meningiomas with MIB-1LI less than 7; 43 were agreed upon to have 
regular shape and 7 to have irregular shape by the two observers; 27 were not matching; of 
these 21 were stated to have regular shape by Observer 1 and 6 were stated to have a regular 
shape by Observer 2.  
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Combination of two parameters 
Analysis of combination of two parameters was done among the study set of cases. Presence 
of both irregular tumor shape and ill defined brain tumor interface in each case corresponded 
to a higher MIB-1LI according to Observer 2. (p = 0.05 in Observer 2 and 0.3 in Observer 1) 
In correlation with histological grading, presence of both irregular shape and ill defined brain 
tumor interface was found to be statistically significant according to Observer 1. (p = 0.05 in 
Observer 1 and p = 0.09 in Observer 2) (Figure 2, Table 15) 
The observations on each parameter was compared for each individual case as shown in the 
Appendix IV; findings on the WHO grade II / III meningiomas group cases are highlighted. 
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Table 16 shows the statistical significance of each of the three parameters which was 
calculated by performing Chi square tests, in cross tabulation with the MIB-1LI values. This 
showed that of the three parameters only shape of tumor had statistical significance (p=0.05) 
in one of the observers and the rest of the observations had no statistical significance. 
Inter-observer Variation 
The consistency of these observations was evaluated by calculating the inter-observer 
variability indicated by the ‘Kappa’ value for individual parameters and for the Total 
Radiological Score.  
In observations on peritumoral edema, there was agreement on a total of 108 cases, thus 
showing that it has a good inter-observer agreement. (K=0.675) (Table 17) 
There was agreement on 95 of 127 (K= 0.305) cases on tumor brain interface as shown in 
Table 18; the inter-observer agreement as shown by Kappa value being poor. 
Similar cross tabulation for observations on shape of tumor showed an agreement on 21 
irregular and 65 regular shapes of tumors out of 127 cases. The kappa was calculated to be 
0.302, which is poor. (Table 19) 
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Table 20 shows the Total Radiological Scores for Observers 1 and 2.  It is clear that the 
figures along the diagonal represent the number of patients in whom both observers assigned 
the same Total Radiological Score, which is 61/127 (48%). The figures to the left of the 
diagonal represent the number of cases in which Observer 1 quoted a score higher than 
Observer 2, that is 9/127 (7.1%), while those to the right of the diagonal depict the number of 
cases where Observer 2 quoted a score higher than Observer 1 that is 57/127 ( 44.9%).  
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Discussion   
Introduction 
Meningioma is the commonest benign intracranial tumor, accounting for 13–26% of all 
primary intracranial tumors.[1] They arise from the meninges, can progressively enlarge 
leading to compression of the surrounding neural tissue and cause neurological deficits, focal 
or generalized seizures.[6] Though generally benign in nature, these tumors could show 
aggressive behavior. A number of factors have been used to predict aggressive behavior in 
these tumors include age, gender, size and location of tumor, radiological characteristics 
histopathology and immunohistochemistry. The extent of tumor resection at surgery is 
classified based on Simpson`s [61] criteria and it has been shown in subsequent studies [10, 62] 
that tumor recurrence depends on Simpson`s Grade of tumor excision. A few studies [25, 26]   
have shown  that the majority  (60-65%) of patients with incidental meningiomas show no 
growth  on follow up for 5 years. Therefore elderly patients, or those with high medical risk 
factors, with small asymptomatic tumors can be followed up on an annual basis. Prediction of 
the aggressiveness of these tumors therefore will help in appropriately counseling these 
patients towards most appropriate modality of treatment with radiosurgery emerging as a safe 
and effective option. 
WHO GRADING 
Meningiomas are classified into WHO grades I, II and III based on their histological 
characteristics. [1] One of the most commonly used classification and grading systems for 
meningiomas was set forth by the WHO in 2000  and was very recently updated in 2007. [1, 11] 
This system summarizes much of what is known about the features seen on routine 
histological examination that predict aggressive behavior in meningioma. 
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The WHO classification in 1993 [63]  defined Grade II meningiomas as those "in which several 
of the following features are evident: frequent mitoses, increased cellularity, small cells with 
high nucleus/cytoplasm ratios and/or prominent nucleoli, uninterrupted patternless or sheet 
like growth, and foci of spontaneous or geographic necrosis." An anaplastic or malignant 
(Grade III) meningioma exhibited "histological features of frank malignancy far in excess of 
the abnormalities noted in atypical meningiomas."  These definitions were vague and caused 
difficulty in classifying meningiomas. Independent researchers from Mayo clinic then, 
applied newer criteria; retrospectively reclassified their meningiomas previously classified by 
WHO 1993 criteria and found better correlation between histology and recurrence rates. The 
re-assessment resulted in change of grade in 13% of tumors and a 25% increase in Grade II 
tumors. [63] These criteria were applied in the WHO 2000 classification of meningiomas, 
which now included necrosis, as a feature of atypia.  Subsequently brain invasion was 
included as a criteria for defining atypia and is the only significant change brought in the 
2007 classification of meningiomas. [11]  
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Incidence of atypical /malignant meningiomas in literature 
Owing to the repeated modification to the WHO classification, true incidence of atypical/ 
malignant meningiomas has not been determined. In 319 cases of meningiomas, 294 (92%) 
were found to be benign, 20(6.2%) were atypical and 5 (1.7%) were anaplastic. [62]  Pearson et 
al [64] in their study of 440 meningiomas had 337 (77%) benign, 77 (17%) atypical and 41 
(9%) anaplastic meningiomas. 
 In our study of 246 meningiomas, 188 (76.4%) cases were WHO grade I, 52 (21.1%) were 
WHO grade II and 6 (2.4%) WHO grade III meningiomas. The distribution was in 
accordance with the literature. The classification followed here is based on the criteria 
proposed by WHO 2000 classification of meningiomas.  
MIB-1LI 
As pointed out by various studies, there is a statistically significant correlation between high 
MIB-1LI values, histological grading and recurrence rates of meningiomas. [18, 19, 20] There 
have been studies showing higher incidence of atypical meningiomas and a higher range of 
MIB-1LI values in the pediatric age group. [23]  A study from our institution showed that a 
cut-off value of 7% for MIB-1LI had highest validity in diagnosis of atypical 
meningiomas.[22]  The cut-off for MIB-1LI used in various studies include 3 %, [23] 3.2%,[65]  
and 4.2%. [64] 
Mitotic indices are known to correlate roughly with volume growth rate. [3] MIB-1LI shows a 
steady increase from benign through atypical to anaplastic varieties. [2, 3, 31, 62, 66]  Certain 
studies showed values of MIB-1 LI to be ranging from 1·00–1·35% for grade I, to 1·9–9·3% 
for grade II or atypical, and 5·6–19·5% for grade III or anaplastic meningiomas [66] 
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MIB-1LI and WHO grading in our study 
The mean MIB-1LI was 11.8% for atypical and 3.7% for benign meningiomas the difference 
in the two groups being statistically significant (p value = 0.0001). Out of the 127 cases, 50 
had MIB-1LI of ≥7% and 77 had MIB-1LI of < 7%. Of the 41 atypical tumors in the study, 
36 had a MIB-1LI of ≥ 7% while of the 86 benign tumors, 72 had a MIB-1LI of <7%. Thus 
MIB-LI had a sensitivity of 87.8% and specificity of 83.7%, making it a useful additional tool 
to the WHO grading system. 
Radiological features: 
Peritumoral brain edema  
Numerous studies in the past have correlated PTBE with various clinico-pathological 
parameters in meningiomas. [28, 38, 31, 39-50]   The various factors that are thought to play a role 
in the PTBE associated with meningiomas include size of the tumor, histological subtype, 
vascularity, level of growth factors like VEGF, venous stasis and brain invasion. [42, 43, 44]   Ide 
et al [42]  who studied 57 cases of intracranial meningiomas and found that edema was 
significantly correlated with  MIB-1LI  and tumor size.   Lee et al [47] correlated edema with 
histological grade (grade I vs. grade II/III) of WHO histological subtypes. On the other hand, 
Chen et al [31] found no correlation between the degrees of surrounding edema or contrast 
enhancement with histopathological findings. Simis et al [67] showed that peritumoral edema 
had a positive correlation with high recurrence rates (p=0.042) but did not comment on the 
MIB-1LI or histological grading.   
. 
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Despite many studies on peritumoral brain edema, in meningiomas, the exact etiology 
remains elusive. Studies that have considered size of the tumor as a possible etiology have 
not shown consistent correlation, [47, 48,  49] as there were small meningiomas with large 
amount of edema and very large meningiomas with negligible edema. A few studies [44, 49, 50] 
have considered proximity of tumor to venous sinuses as another factor causing edema, but 
others have not supported this theory. [44] The correlation of peritumoral brain edema with 
WHO grade of the tumor is also poor, although studies [42, 47] have shown that higher grades 
of edema is seen with higher WHO grade of the tumor. This finding is not restricted to 
atypical meningiomas as high grades of edema have been associated with certain benign 
variants too. [44, 45, 46]    
Our study did not show any correlation between the presence of peri-lesional edema and a 
high MIB-1LI (>7%) from the findings of both observers.  The negative predictive value was 
too low (64.5 and 65.7 for Observer 1 and Observer 2 respectively) thus suggesting that the 
absence of peritumoral edema cannot be an indicator of benign nature of meningiomas. It was 
noted that the first observer had stricter criteria for definition of presence of edema and the 
Observer 2 was more general in his definition of presence of edema. This enabled Observer 2 
to pick more cases of edema in the group with MIB-1LI more than 7%, giving him a higher 
sensitivity (74% in comparison of 64% for Observer 1) but he had to compromise on 
specificity (32.4% in comparison to 42.8% for Observer 1.) It is notable that this parameter 
had maximum inter observer agreement with a Kappa of 0.67. Figure 3 shows a T2W image 
showing a large meningioma with no edema around it as agreed upon by the two observers of 
our study and Figure 4 shows MRI of patient with parasagittal meningioma which had 
disagreement between the observers for presence of edema. Observer 1 recorded it to have 
edema where as Observer 2 recorded it as a case with no peritumoral brain edema.  
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Tumor-brain interface  
 Although several studies  report on tumor-brain interface of meningiomas, [41, 52, 54, 56, 58]   
only a few of them have attempted a correlation with the with biological behavior of these 
tumors. [52, 58]  These latter studies have found that an indistinct tumor-brain interface on 
imaging is associated with recurrent meningiomas. Hashiba et al [3] found that the tumors 
with a distinct peritumoral rim of CSF had a lower mean MIB-1LI of 2.3% in comparison to 
those with an indistinct tumor-brain interface which had a mean MIB-1LI of 3.7% and this to 
be statistically significant. Our study showed that presence of ill-defined tumor-brain 
interface alone in the scan did not correspond to higher MIB-1LI. This parameter in our study 
had a high specificity of 92% but a very low sensitivity of 12% for Observer 1 and moderate 
specificity of 70.1 and low sensitivity of 38% for Observer 2 in predicting tumors with MIB-
1LI≥7%. However, the inter-observer variability for this parameter was high as suggested by 
the Kappa value of 0.305.  Figure 5 shows MRI of patient with well defined tumor-brain 
interface as agreed upon by both the observers and Figure 6 shows MRI of a pterional 
meningioma with disagreement between the observers for tumor-brain interface.  
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Shape of the tumor 
Various studies in literature have classified tumor-brain interface as round, lobulated and 
mushrooming type [2, 39, 54] The shape of tumor was classified as round (smoothly curved 
surfaces pushing against the brain), lobulated (nodular surfaces pushing against the brain) and 
mushrooming meningiomas. Mushrooming tumors were defined as having a prominent 
pannus extending over the cerebral surface from the globoid portion of the tumor [39] 
Shape and tumor recurrence: 
 Nasaku et al [54] followed up 100 patients who underwent gross total removal of 
meningiomas for at least 5 years or until tumor recurrence. Preoperative radiological findings 
and clinical characteristics were assessed. On univariate analysis, tumor size and shape, 
relation to the major sinuses, calcification, bone changes and characteristics of the tumor-
brain interface were significant predictive factors for recurrence.  Multivariate analysis 
revealed that only the shape of the tumor was significant; both mushrooming and lobulated 
meningiomas were more likely to recur than the round ones. 
 In another study Idan et al [59] studied 201 patients of meningiomas where shape of the 
tumor, edema, calcification and vascularity were studied with respect to tumor recurrence, 
that occurred in 16 patients An irregular tumor shape was the only factor that was associated 
with recurrence. Moreover, mushrooming appeared to be the radiological finding that 
strongly correlated with the higher WHO grade, and this finding seemed to be corroborated 
by other authors. [2, 39]  
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Irregularity Index   
 Nawashiro et al [60] suggested quantification of irregularity of shape using an index called 
irregularity index (IR) defined as a ratio between the square of the perimeter and the area of 
the tumor. This index would be least in a tumor with circular shape and higher in irregular 
tumors. They found that IR was significantly higher in the atypical and anaplastic 
meningiomas compared to the benign variety. They also found a significant correlation 
between the IR and MIB-1LI. 
We found that a tumor with an irregular shape had a statistically significant correlation with 
higher MIB-1LI for Observer 2 (p=0.05) but not for Observer 1. The shape of the tumor had a 
high specificity of 83% and a low sensitivity of 30% in Observer 1 and a sensitivity of 53% 
and specificity of 63.6% in Observer 2, in correlation with MIB-1LI values.  This highlights 
the fact that Observer 1 had stricter criteria for defining irregular shape. On the other hand, 
Observer 2 was more liberal in defining irregular shape, resulting in a slightly better 
sensitivity, but lost out on specificity in comparison with Observer 1. Out of the 50 
meningiomas with MIB-1LI ≥ 7%, 14 were found to have an irregular shape of tumor by both 
observers, 22 had a regular shape by both observers; while 14 did not match. The inter-
observer variability was high for this parameter, suggested by a kappa of 0.302. Figure 7 
shows a meningioma with irregular shape as agreed upon by both the observers, where as 
figure 8 shows a meningioma with disagreement between the observers for the tumor shape.  
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Combination of  Shape and tumor-brain interface 
Analyzing the outcome by combining two of these parameters, namely shape of the tumor 
and tumor-brain interface; we found that the results were statistically significant in 
correlation with MIB-1LI values for Observer 2  (p=0.05) and with WHO grading for 
Observer 1 (p=0.05). Thus, combination of these two parameters correlated with the 
biological behavior better than when they were considered separately. 
Previous study on pre-opeative radiological scoring for meningiomas 
Hashiba e t al [3] in their study on 90 cases,  found statistically significant positive correlation 
of MIB-1LI with shape of the tumor, with the mean MIB-1LI of irregularly shaped tumors 
being higher (4.6%) than regular shaped ones (1.8%).  Similarly it was seen that tumors with 
edema and indistinct tumor brain interface had higher MIB-1LI. They devised a scoring 
system with these three radiological parameters and the total radiological score (TRS) was 
calculated. They had 32, 18, 19 and 21 patients with total radiological scores of 0, 1, 2 and 3 
respectively. Their corresponding median MIB-1LI values were 1.3, 1.5, 1.6 and 2.7%.  
Although there was an increase in the mean MIB-1LI values with increasing total 
radiological score, it can be noted that the difference between the mean MIB-1LI for the 
lowest TRS and highest TRS was minimal. These authors did not use the WHO grading 
system. The authors concluded that TRS could not be applied clinically, in view of the high 
inter-observer variation. Our study also showed a high inter-observer variation with TRS. 
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Inter-observer variation  
The consistency of these outcomes in routine clinical practice is questionable as indicated by 
the high inter-observer variability for all parameters except perilesional edema.  This is 
shown in Table 20, (page 43) which tabulates the total radiological scores for Observers1 and 
2.  It is clear that the figures along the diagonal represent the number of patients in whom 
both observers assigned the same total radiological score that is 61/127 (48.0%). The figures 
to the left of the diagonal represent the number of cases in which Observer 1 quoted a score 
higher than Observer 2, that is 9/127 (7.1%),while those to the right of the diagonal depict the 
number of cases where Observer 2 quoted a score higher than Observer 1 that is 57/127  
(44.9%). This reflects the fact that the observers differed greatly in how strictly they applied 
each of the three parameters, and that Observer 1 used very strict criteria while Observer 2 
had more general criteria.  As discussed earlier, an ideal screening tool should fulfill the 
essential criteria of repeatability and validity, which in turn depends on good sensitivity and 
specificity.  The observers in our study were not given standardized criteria for recognition of 
the various radiological parameters on the MRI and this could have contributed towards the 
high inter-observer variability.   
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Summary  
Perilesional edema – There is good inter-observer agreement but no statistical significance 
in predicting high MIB-1LI or histological grade of meningiomas. 
Tumor Brain interface – This parameter has high specificity in detecting atypical 
meningioma for Observer 1, but it also has high inter observer variability. Moreover it has a 
low sensitivity which makes it a bad screening tool for detecting aggressive nature of 
meningiomas. 
Shape of tumor – This has high specificity for Observer 1 and statistical significance in 
predicting high MIB-1LI in Observer 2.  Irregular shape of tumor has good positive 
predictive value for atypical meningiomas. But even this parameter was found to have a high 
inter observer variability and low sensitivity; thus making it an inappropriate screening tool 
for picking up atypical nature of meningiomas pre-operatively. 
 Combination of tumor brain interface and shape When used concurrently, tumor brain 
interface and shape of tumor was found to have a statistically significant correlation with  
MIB-1LI and histological grading.  
Total Radiological Score also exhibited a high inter observer variability rendering it unfit to 
be used on a regular basis for prediction of biological behavior of meningiomas pre 
operatively. This was probably because of peritumoral edema. 
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It is possible that standardization of the radiological criteria may ensure uniform recognition 
and may improve the inter observer variation, but may not contribute to improving the 
sensitivity and specificity. This is because Observer 1 and Observer 2 represent extremes in 
the spectrum of preoperative diagnosis, with Observer 1 being very strict obtaining a high 
specificity but a low sensitivity and Observer 2 being more liberal and yet not being able to 
raise the sensitivity to acceptable levels. A good screening tool should fulfill the essential 
criteria of acceptability, repeatability and validity.  A screening tool is considered to be valid 
based on its sensitivity and specificity. These two parameters along with accuracy form the 
inherent properties of screening test. Sensitivity is the ability of the test to identify correctly 
all that is “true positives” and specificity is the ability of the test to identify correctly all that 
is “ true negatives” An ideal screening tool should be 100% sensitive and 100% specific, but 
in practice a test with a high sensitivity and moderate specificity is acceptable. In this study 
we find that the sensitivity of the MR findings was highest for edema (70%), while for other 
parameters the sensitivity was very poor making it a poor screening test. 
 Drawbacks of the study: 
The study was retrospective. MR images from outside centers were also included in the 
study, causing variability in the quality of the images. There was no standardization of 
criteria for identification of various parameters on the images.  Statistically better inter-
observer agreement may have been expected had there been standardization in scoring for 
each parameter. No attempt was made to quantify the radiological parameters. 
Recommendations: 
A prospective study with uniformity in the MR imaging in terms of the sequences that are 
studied is needed. The probability of identifying peritumoral edema may be better when both 
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T2W and FLAIR images are used for studying the perilesional edema in all patients. Unlike 
in a retrospective study a prospective study can ensure that all the patients have the required 
sequences of MRI.  Similarly, the efficacy of identifying tumor-brain interface and shape of 
tumor will be better if all patients had contrast images.  
Quantification of each parameter:  
1. Edema: Calculation of edema index may help in grading the edema.  The grade of edema 
probably will have better correlation with MIB-1LI than just its presence or absence. 
Quantification also has the likelihood of decreasing the inter-observer variability.   
2. Tumor- brain interface should have been assessed from post contrast MRI images and this 
probably would have decreased the inter-observer variability.  There should be a method of 
grading tumor- brain interface, probably in terms of ratio of the perimeter of the surface of 
the tumor that has ambiguous interface with brain, in relation to total perimeter of the tumor.  
There have been no studies in literature that has looked into this aspect.  Does the extent of 
indistinct tumor-brain interface in the tumor correlate better with the higher MIB-1LI than 
just presence or absence of indistinct tumor-brain interface?  
3. Shape of tumor: The Irregularity index, [60] could be applied to quantify the irregularity of 
tumor. This quantification may help in reducing the inter-observer variability on this 
parameter, and improve the positive predictive vaue. 
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Conclusion 
Magnetic resonance image finding of irregular tumor shape was found to have a statistically 
significant correlation with high MIB-1LI of meningiomas. An irregular tumor in 
combination with poor tumor-brain interface positively correlated with atypical /malignant 
meningiomas. However, the high inter-observer variability and low sensitivity associated 
with these observations warrants standardization and quantification of radiological 
parameters before they may be applied in clinical practice. 
 
 
 
 
Table 1 Distribution of Intracranial Meningiomas in Cushing’s series. [4] 
Location of tumor Incidence 
Convexity      34% 
Parasagittal    22% 
Sphenoid ridge                 17% 
Lateral ventricular 5% 
Tentorium 4% 
Cerebellar convexity         5% 
Tuberculum sellae            3% 
Intraorbital 2% 
Cerebellopontine angle 2% 
Olfactory groove 3% 
Foramen magnum 1% 
Clivus 1% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2:  Summary of the 2007 WHO Grading Scheme for Meningiomas [11] 
WHO GRADE HISTOLOGICAL SUBTYPE  HISTOLOGICAL 
FEATURES 
I Meningothelial 
 Fibroblastic 
 Transitional 
 Angiomatous 
 Microcystic 
 Secretory 
Lymphoplasmacytic 
 Metaplastic 
Psammomatous 
The tumors in this  grade do not 
fulfil the criteria for Grade II or 
III 
II Chordoid  
Clear cell 
There are 4 or more mitotic cells 
per 10 high power fields and/or 
3 or more of the following: 
increased cellularity, small cells, 
necrosis, prominent nucleoli, 
sheeting, and/or brain invasion 
in an otherwise Grade I tumor 
III Papillary 
 Rhabdoid 
 There are 20 or more mitoses 
per 10 high power field and/or 
obviously malignant cytological 
characteristics such that tumor 
cell resembles carcinoma, 
sarcoma, or melanoma 
 
 
 
 
 
 
Table 3 Histologic and immunohistochemical features of prognostic significance in   
meningiomas 
 
Absence of immunoreactivity for progesterone receptors. 
Loss of lobular pattern (sheeting) 
Hypercellularity 
Cytologic atypia with macronucleoli 
Increased mitotic rate (>/= 4/10 high power field) 
Necrosis (in the absence of prior embolization) 
Elevated MIB-1index 
Small cell change 
Invasion of the brain 
Cellular anaplasia 
Histologic subtype (Rhabdoid, papillary, chordoid, clear cell) 
Absence of immunoreactivity for progesterone receptors. 
 
 
 
 
 
 
 
 
 
  
Table 4 Criteria for radiological scoring 
CRITERIA                                             
Perilesional edema  Absent = 0 Present = 1 
Tumor-brain interface   Well defined = 0 Ill-defined = 1 
Shape of tumor  Regular = 0 Irregular = 1 
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig 1 Correlation between MIB-1 labeling index and histological grading of the meningiomas 
 
 
Table 5: Correlation between MIB1-LI and histological grading showing its significance. 
 MIB-1 LI VALUE HISTOLOGICAL 
GRADING 
   
 Atypical Benign Total  
≥7 % 36 14 50 PPV= 72 
< 7% 5 72 77 NPV= 93.5 
Total 41 86 127  
 Sensitivity= 87.8  Specificity = 83.7 
 
 
 
 
Table 6 Identification of perilesional edema in the study set by the two observers, in relation to WHO 
grading 
 EDEMA Observer 1  Observer 2  
 WHO I WHO II/III WHO I WHO II/III 
Present 52 24 59 30 
Absent 34 17 27 11 
 
Table 7 Peritumoral edema crosstabulated against MIB-1LI for the two observers  
Observer 1 MIB-1LI 
EDEMA ≥7(n=50) < 7(n=77)  
PRESENT 32 44 Positive predictive value= 42.1% 
ABSENT 18 33 Negative predictive value= 64.7% 
 Sensitivity=64% Specificity=42.8%  
Observer 2 MIB-1LI 
EDEMA ≥7(n=50) < 7(n=77)  
PRESENT 37 52 Positive predictive value= 41.5% 
ABSENT 13 25 Negative predictive value= 65.7% 
 Sensitivity=74% Specificity=32.4%  
 
Table 8 Various statistical parameters on significance of edema with respect to MIB1-LI and WHO grade as per 
the two observers 
 Observer 1 (%)  Observer 2 (%)  
 MIB-1LI WHO GRADE MIB-1LI WHO GRADE 
Sensitivity 64 58.5 74 73.1 
Specificity 42.8 39.5 32.5 31.4 
Positive Predictive 
Value 
42.1 31.5 41.5 33.7 
Negative Predictive 
value 
64.7 66.7 65.7 71.1 
 
 
 
 
Table 9 Tumor-Brain interface as observed by the two observers in relation with WHO grading 
TUMOR-
BRAIN 
INTERFACE 
Observer 1  Observer 2  
  WHO I WHO II/III WHO I WHO II/III 
Ill-defined 7 5 25 17 
Well defined 79 36 61 24 
 
Table 10 Tumor-Brain interface cross tabulated against MIB-1LI for the two observers 
Observer 1 MIB-1 LI 
Tumor-brain 
interface 
≥7(n=50) < 7(n=77)  
Ill-defined 
margins 
6 6 Positive predictive value 
= 50% 
Well defined 
margins 
44 71 Negative predictive value 
= 61.7% 
 Sensitivity=12% Specificity=92.2%  
 
 
 
 
 
Table 11 Various statistical parameters on significance of tumor-brain interface with respect to MIB1-LI and 
WHO GRADE as per the two observers 
 Observer 1 (%)  Observer 2 (%)  
 MIB-1LI WHO GRADE MIB-1LI WHO GRADE 
Sensitivity 12 12.2 38 41.5 
Specificity 92.2 91.9 70.1 70.9 
Positive Predictive 
Value 
50 41.7 45.2 40.5 
Negative Predictive 
value 
61.7 68.7 63.2 71.7 
 
 
Observer 2 MIB-1 LI 
Tumor-brain 
interface 
≥7(n=50) < 7(n=77)  
Ill-defined 
margins 
19 23 Positive predictive value 
=45.2% 
Well defined 
margins 
31 54 Negative predictive value 
=63.2% 
 Sensitivity=38% Specificity=70.1%  
  
Table 12 Shape of tumor in correlation with their WHO grading 
TUMOR 
SHAPE 
Observer 1  Observer 2  
  WHO I WHO II/III WHO I WHO II/III 
Irregular 14 14 31 24 
Regular 72 27 55 17 
 
Table 13 Tumor shape cross tabulated against MIB-1LI for the two observers. 
Observer 1 MIB-1LI 
Tumor Shape ≥7(n=50) < 7(n=77)  
Irregular 15 13 Positive predictive value=53.5 % 
 regular 35 64 Negative predictive value= 64.6% 
 Sensitivity=30% Specificity=83%  
Observer 2 MIB-1LI 
Tumor Shape ≥7(n=50) < 7(n=77)  
Irregular 27 28 Positive predictive value=49.1% 
 Regular 23 49 Negative predictive value=68.1% 
 Sensitivity=54% Specificity=63.6%  
 
Table 14 Various statistical parameters on significance of shape of tumor with respect to MIB1-LI and WHO 
GRADE as per the two observers 
 Observer 1 (%)  Observer 2 (%)  
 MIB-1LI WHO GRADE MIB-1LI WHO GRADE 
Sensitivity 30 34.1 54 58.5 
Specificity 83 83.7 63.6 63.9 
Positive Predictive 
Value 
53.5 50 49.1 43.6 
Negative Predictive 
value 
64.6 72.7 68.1 76.4 
 
 
 
 
  
 
Figure 2: Observations on combination of two parameters; shape of tumor and tumor-brain 
interface 
 
 
 
Table 15 Combination of tumor-brain interface and tumor shape in comparison with the 
MIB-1 LI as per the two observers 
 
 
 
 
 
 
MIB-1 LI 
value 
Observer 1  
Both shape 
and 
interface 
irregular 
Observer 2   
Both shape 
and 
interface 
irregular 
Observer  1  
Interface 
alone 
irregular  
Observer  2  
Interface 
alone 
irregular 
Observer 1  
Shape 
alone 
irregular 
Observer 2  
Shape 
alone 
irregular 
Observer 1  
Both 
regular 
Observer 2  
Both 
regular 
≥7(n=50) 3 18 3 1 12 9 32 22 
< 7(n=77) 3 23 3 0 10 5 61 49 
Table 16 Statistical significance of edema, tumor-brain interface and shape of tumor in correlation 
with MIB1-LI ( p values obtained by performing Chi square tests) 
 p value (Observer 1) p value (Observer 2) 
Peritumoral edema 0.441 0.437 
Tumor-brain interface 0.428 0.341 
Shape of tumor 0.081 0.05 
 
Table 17 Crosstabulation for peritumoral edema as per the two observers 
 
 
 
 
 
Table 18 Crosstabulation for tumor-brain interface as per the two observers 
 Observer 2   
Observer 1 Ill defined Well defined Total 
Ill defined 11 1 12 
Well defined 31 84 115 
Total 42 85 127 
 
Table 19 Cross tabulation for tumor shape as per the two observers 
 
 
 
 
 
 
 
 
 Observer 2   
Observer 1 "Present" "Absent" Total 
"Present" 73 3 76 
"Absent" 16 35 51 
Total 89 38 127 
 Observer 2    
Observer 1 Irregular Regular Total 
Irregular 21 7 28 
Regular 34 65 99 
Total 55 72 127 K=0.302
K= 0.305
K =0.675 
 Table 20 Cross tabulation between the total radiological scores as interpreted by the two observers 
K = 0.285 Observer 2 total  score  
0 1 2 3  
Observer 1  
total score 
0 23 11 7  0  
1 4 30 9 16  
2 1 4 5 14  
3  0  0  0 3  
Total     127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3: T2W MRI showing large meningioma with no peritumoral edema as agreed upon 
by both the observers. 
 
 
Figure 4 Parasagittal meningioma with disagreement on presence of edema between the 
observers. 
 
 
 
 
 
 
  
Figure 5 Meningioma with well defined tumor-brain interface as agreed upon by both 
observers. 
 
 
 
Figure 6 Meningioma with disagreement between observers for tumor-brain interface.  
Histopathology of this tumor was Angiomatous meningioma, WHO grade I, with MIB-1 
proliferating index of 4%, 
  
 
 
 
 
 
 
 
 
 
 
Figure 7 showing a meningioma with irregular shape as agreed upon by both observers. 
Histology was consistent with chordoid meningioma, WHO grade II, MIB-1LI 10% 
 
 
Figure 8: Showing a meningioma with disagreement between the observers for irregularity 
of shape. Observer 1 called it irregular and observer 2 called it regular. Histopathology was 
consistent with WHO grade 1 with MIB 1 proliferation index 9% 
 
  
Immunohistochemistry staining of meningioma showing a MIB-1LI of 1% 
 
 
 
 
 
 
Immunohistochemistry staining of meningioma showing a MIB-1LI 7% 
 Immunohistochemistry staining of meningioma with MIB-1LI of 40% 
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Appendix -1 
Methodology of MIB-1 index assessment: 
Representative 5µ sections of each case were mounted on poly-L-Lysine coated slides and 
incubated overnight at 370˚C. Sections of tonsil were used as positive control. Negative 
controls were achieved by omitting the primary antibody. Sections were deparaffinized 
followed by rehydration in decreasing ethanol concentrations and placed in distilled water. 
Antigen retrieval was done by pressure cooking.13 10mM sodium citrate (pH 6.0) was boiled 
in a pressure cooker. The slides were placed in the boiling buffer and the lid of the pressure 
cooker closed. The cooker was allowed to come to full pressure. After 2 minutes of boiling at 
full pressure, the cooker was cooled by quenching in cold running tap water. The slides were 
then removed quickly and placed in distilled water for 2 changes and allowed to cool to room 
temperature, and then transferred to 0.05 M Tris (Aldrich) buffered saline (pH 7.4), care 
being taken to ensure that the slides did not dry. The slides were individually drained of 
buffer, by gentle tapping, followed by careful wiping of excess liquid around the section. The 
sections were then covered with normal human pooled serum (1:5 dilution, Institutional 
Blood Bank) and incubated for 15 minutes. All excess liquid was drained off the slide by 
gentle tapping and the sections covered with the diluted MIB-1 monoclonal antibody (DAKO 
Patts, Denmark), at a dilution of 1:75 and incubated for 30 minutes at room temperature 
(240C). The slides were then rinsed in Tris-buffered saline 3 times for 5 minutes each. The 
sections were then drained and covered by diluted secondary antibody, biotinylated rabbit 
anti mouse (1:200 dilution, DAKO Patts, Denmark) and incubated for 30 minutes at room 
temperature. The slides were then rinsed in Tris-buffered saline 3 times for 5 minutes each. 
Endogenous peroxidase was blocked with 0.5% hydrogen peroxidase (Qualigens) in 
methanol by incubating the slides covered with solution for 30 minutes. The sections were 
rinsed in Tris-buffered saline 3 times, for 5 minutes each. The sections were then drained and 
covered with peroxidase conjugated avidin (1:200 dilution, DAKO Patts, Denmark) and 
incubated for 30 minutes. The slides were rinsed with 3 changes of Tris-buffered saline for 5 
minutes each. The slides were then developed using freshly prepared diaminobenzidine 
tetrahydrochloride solution (DAKO Patts, Denmark) containing hydrogen peroxide, for 10 
minutes. At this point positive controls were checked to ascertain the end of incubation. The 
sections were counterstained with Harris Hematoxylin for 10 seconds. The sections were then 
dehydrated, cleared, and mounted with DPX as mounting medium. Cells with brown nuclei 
were considered immunopositive for MIB-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 2 
                                                                  
                                         PROFORMA 
Prediction of MIB-1 index based on radiological criteria 
CASE NUMBER: 
HOSPITAL NUMBER: 
RADIOLOGICAL SCORE 
CRITERIA                         SCORE 
Peritumoral edema in 
MRI 
Absent Present  
Brain tumor interface  
on MRI 
Well defined Ill-defined  
Shape of tumor on 
MRI 
Regular Irregular  
 
 
TOTAL SCORE:  
                                                                
           -2- 
                                                              PATHOLOGY 
BIOPSY NUMBER 
HISTOLOGICAL GRADING 
WHO I WHO II WHO III 
Meningothelial meningioma 
 
 
 
Atypical 
 
 
 
Rhabdoid 
 
Fibrous 
Transitional 
 
Psammomatous 
 
Clear cell 
 
Papillary 
 
Angiomatous 
 
Microcystic 
 
Secretory 
 
Chordoid Anaplastic 
 
Lymphoplasmocyte – rich 
 
Metaplastic 
 
     
    MIB-1 INDEX:  
 
Appendix 3 
Radiological Scoring of the study set of 127 cases by the two observers, their MIB1 LI value and histological grading 
 
PATIENT 
NO: 
EDEMA    TUMOR‐ BRAIN 
INTERFACE 
SHAPE TOTAL SCORE GRADE MIB‐1LI
  Observer1  Observer2 Observer1 Observer2 Observer1 Observer2  Observer1 Observer2
1  0  0 0 0 0 0 0  0 A 9
2  1  1 0 0 1 1 2  2 A 15.1
3  1  1 0 1 0 1 1  3 T 5.4
4  1  1 0 0 0 0 1  1 T 1
5  0  0 0 0 0 0 0  0 T 1
6  1  1 0 0 0 0 1  1 T 11
7  1  1 0 1 0 1 1  3 T 3
8  0  1 0 0 0 0 0  1 A 10
9  1  1 1 1 0 1 2  3 A 8
10  1  1 1 0 0 0 2  1 T 2.8
11  1  1 0 0 0 1 1  2 T 3
12  1  1 0 0 0 0 1  1 T 6
13  0  1 0 0 0 0 0  1 T 2
14  1  1 0 0 0 0 1  1 T 2
15  1  1 1 1 1 1 3  3 T 3
16  0  0 0 1 0 1 0  2 T 5
17  1  1 0 1 0 1 1  3 T 4.8
18  1  1 0 1 0 1 1  3 A 8
19  0  1 0 0 0 0 0  1 T 2
20  1  1 0 1 1 1 2  3 A 7
21  1  1 0 1 1 1 2  3 A 8
22  0  0 0 0 0 0 0  0 T 2
23  1  1 0 0 0 1 1  2 T 8
24  0  0 0 1 0 1 0  2 T 2
25  0  0 0 0 0 0 0  0 A 10
26  1  1 0 0 0 0 1  1 T 12
27  1  1 1 1 1 1 3  3 T 4.8
28  1  1 0 0 1 0 2  1 T 3
29  0  1 0 0 1 0 1  1 T 2
30  0  0 0 0 0 0 0  0 A 9.2
31  0  0 0 0 1 0 1  0 T 4.5
32  1  1 0 0 0 0 1  1 T 2
33  1  1 0 1 0 1 1  3 T 3
34  1  1 0 0 0 1 1  2 A 12
35  0  0 0 0 0 0 0  0 T 4
36  1  1 0 0 0 1 1  2 A 6
37  1  0 0 0 1 0 2  0 A 7
38  1  1 0 1 1 1 2  3 T 3
39  0  0 0 0 0 0 0  0 T 11.5
40  0  0 0 0 0 0 0  0 T 0.8
41  0  1 0 0 0 0 0  1 T 3.8
42  0  0 0 0 0 0 0  0 T 5
43  0  0 0 0 0 0 0  0 A 23
44  0  0 0 0 0 0 0  0 T 1
45  0  1 0 1 1 1 1  3 A 20
46  0  0 1 1 1 1 2  2 T 6
47  1  1 0 1 0 1 1  3 T 2
48  0  1 0 1 1 1 1  3 A 10
49  1  1 0 1 0 1 1  3 T 2
50  0  0 0 1 1 1 1  2 A 12
51  1  1 1 1 0 1 2  3 T 5.8
52  1  1 1 1 0 1 2  3 A 11.2
53  0  1 0 0 0 0 0  1 A 12
54  0  1 1 1 1 1 2  3 A 20
55  1  1 0 1 0 1 1  3 T 9
56  1  1 1 1 0 1 2  3 T 8.8
57  1  1 0 0 0 0 1  1 T 1
58  1  1 0 0 0 0 1  1 T 4.5
59  1  1 1 1 0 1 2  3 A 16.5
60  1  1 0 0 0 0 1  1 T 2
61  0  0 0 0 0 0 0  0 T 5
62  1  1 0 0 0 0 1  1 T 7.6
63  1  1 0 0 0 0 1  1 T 9.8
64  1  0 0 0 0 0 1  0 T 2
65  1  1 0 1 1 1 2  3 A 20
66  1  1 0 1 1 1 2  3 T 3
67  1  1 0 1 0 0 1  2 T 10
68  1  1 0 0 0 0 1  1 T 3
69  1  1 0 1 0 1 1  3 T 1.3
70  0  0 0 0 0 0 0  0 T 2
71  1  1 0 0 0 1 1  2 T 3
72  1  1 0 0 0 0 1  1 T 2.8
73  0  0 0 0 0 1 0  1 T 7.5
74  0  0 0 1 0 1 0  2 A 1
75  1  1 0 1 1 1 2  3 T 3.2
76  1  1 0 0 1 0 2  1 T 4.4
77  1  1 0 0 1 1 2  2 A 12.7
78  1  1 0 0 0 0 1  1 T 4
79  1  0 0 0 0 0 1  0 T 2
80  0  0 0 0 0 0 0  0 T 1
81  1  1 0 1 0 1 1  3 T 4
82  0  1 0 0 0 0 0  1 T 2
83  1  1 0 0 1 0 2  1 T 2
84  1  1 0 0 0 0 1  1 A 10.8
85  1  1 0 1 0 1 1  3 T 1
86  1  1 0 0 0 0 1  1 T 4
87  0  0 0 0 0 0 0  0 T 1.3
88  1  1 0 1 0 1 1  3 T 3.2
89  1  1 0 0 0 0 1  1 T 4
90  0  0 0 0 0 0 0  0 T 2
91  1  1 0 1 0 1 1  3 T 3
92  1  1 1 1 1 1 3  3 T 4.2
93  0  0 0 1 0 1 0  2 T 2
94  1  1 0 0 0 0 1  1 A 6
95  0  0 0 1 0 1 0  2 A 17.2
96  1  1 0 0 0 0 1  1 T 11.4
97  1  1 0 1 0 1 1  3 A 15
98  0  0 1 1 1 1 2  2 A 24
99  0  0 0 0 0 0 0  0 T 6.5
100  0  0 0 0 0 0 0  0 A 1.4
101  1  1 0 1 1 1 2  3 A 9
102  1  1 0 0 0 0 1  1 A 15
103  0  1 0 0 0 0 0  1 A 4
104  1  1 0 0 0 0 1  1 T 3.2
105  0  1 0 0 0 1 0  2 T 3.4
106  0  0 0 0 0 0 0  0 T 4.8
107  1  1 0 0 0 0 1  1 T 1
108  1  1 0 0 0 0 1  1 A 7
109  1  1 0 0 0 0 1  1 T 0.5
110  1  1 0 0 0 0 1  1 A 10
111  1  1 0 0 0 0 1  1 A 23
112  1  1 0 1 1 1 2  3 A 15.8
113  0  1 0 0 0 0 0  1 T 2
 114  0  1 0 0 0 1 0  2 A 9
115  0  0 0 0 0 0 0  0 T 3.6
116  0  0 0 0 0 0 0  0 T 2
117  1  1 0 0 0 0 1  1 A 5
118  1  1 0 0 0 1 1  2 A 19
119  1  1 0 0 0 1 1  2 T 2
120  1  1 0 0 0 0 1  1 A 14.5
121  0  0 0 0 1 0 1  0 T 2
122  0  0 0 0 0 0 0  0 T 2.5
123  0  1 0 0 0 0 0  1 T 1
124  0  0 0 0 0 0 0  0 T 4
125  0  1 0 0 0 0 0  1 T 2
126  1  1 0 0 1 1 2  2 T 1.5
127  0  0 0 0 1 1 1  1 A 8.5
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Sl.No NAME OF 
PATIENT 
HOSPITAL 
NUMBER 
BIOPSY 
NUMBER
SEX AGE WHO 
GRADE
LOCATION OF 
TUMOR 
SIZE OF 
TUMOR 
HISTOLOGICAL 
GRADE 
MIB 1 
-LI 
1.  ajay kumar 646877c 14707/05 m 32 II parietal 7x6x6 atypical 9% 
2.  alam mridha 511961c 20300/04 m 34 II parasagittal 4.5x3x4 atypical 15.10%
3.  amina begum 821855c 19271/06 f 48 I right frontal 3x2.5  5.40% 
4.  amir hossain 697141c 24223/05 m 48 I parietal 5x3.5x3  1% 
5.  amita rakshit 900614c 29009/06 f 56 I frontal convexity 6X6x5.3 fibroblastic 1% 
6.  anil mazumdar 841855c 17548/06 m 53 I Intraventricular 3.5X4X4 metaplastic 11% 
7.  Anju 030009d 15801/07 f 48 I Planum sphenoidal 3.7x4x2.1 transitional 3% 
8.  anupam ray 641070c 154489/05 m 38 II parietal 4x3x3 atypical 10% 
9.  Anusuya 005612c 11125/07 f 25 II frontal convexity 4.5x6x7 atypical 8% 
10.  Arup das 027920d 16635/07 m 31 I parasagittal 3.5X3X2.7 psammomatous 2.80% 
11.  ashwin kumar 506037c 24092/04 m 62 I sphenoid wing 3.2x2.7x3.0  3% 
12.  Asim Purkait 643540c 15246/05 m 42 I parietal 5x4x3  6% 
13.  aslam khan 712720c 26379/05 m 48 I frontal 4.7x4  2% 
14.  awadh bihari 
singh 
490191c 23012/04 m 59 I frontal convexity 3.5x3.5x3  2% 
15.  Babul  979798c 12221/07 f 48 I frontal convexity 5.2x2.1x4 angiomatous 
meningioma 
3% 
16.  badrunnessa 639263c 13159/05 f 44 I parasagittal 6x6x6.5 transitional 5% 
17.  bakkiyalakshmi 833696c 17666/06 f 64 I petrous apex 3x4 secretory 4.80% 
18.  bala rani 
banerjee 
520820c 22585/04 f 59 II olfactorygroove 4.9x5.2x5.3 atypical 8% 
19.  bhola kora 682810c 20351/05 m 59 I tentorial 4X4.5X4 meningothelial 2% 
20.  bholanath raj 
bongshi 
568767c 30813/04 m 42 II parasagittal 3.4X4X3.5 clearcell 7% 
21.  bimal bansriar 665928c 22109/05 m 67 II parasagittal 3.5x4x5 atypical 8% 
Table showing clinical details of  the 127 patients included in the study 
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22.  birendra gupta 690165c 22971/05 m 53 I pterional 4.5x3.5x3 angiomatous 2% 
23.  Brojen 004893d 10831/07 m 56 I Falx 5.4X5.4X6  8.00% 
24.  chabbi deb 823572c 16553/06 f 57 I petrous 3.3 X 3.5 transitional 2%
25.  Chafiang aran 877448c 25426/06 f 37 II tentorium 3.5x3.73.2 atypical 10% 
26.  chaya ghosh 796667c 9554/06 m 46 I parasagittal 2.5x3x2  12% 
27.  chinmoyee 941561c 2647/07 f 51 I basifrontal 5x3.2x3.5 secretory 4.80% 
28.  depak dey 636728c 13670/05 m 44 I frontal  5x4x5.6  3% 
29.  dipak ranjan 057941c 17127/04 m 48 I pterion 3x2.1x2.8  2% 
30.  Drupada mondal 489892c 15511/04 m 48 II parietal 5.0x4x3.5 atypical 9.20% 
31.  farida akthar 809381c 11559/06 f 39 I  falcine 3x3.2x3.5  4.50% 
32.  ferdoshi 617286c 10056/05 f 42 I  medial sphenoid 
wing 
3.5x3.7x3 psamomatous 2% 
33.  garata 
koteshwaramma 
763499c 6586/06 f 45 I Parasagittal 5x3.5x2.6  3.50% 
34.  george 771572c 4052/06 m 58 II Basifrontal 3.1x2.5x2.5 atypical 12% 
35.  gita dawn 849312c 20007/06 f 61 I petrous  2.5x2x2.5 psammomatous 4% 
36.  haji mohammud 
azirruddin 
796941c 9641/06 m 61 II Falx 4.8x4x3.8 atypical 7% 
37.  halima begum 738129c 31071/05 f 50 II cerebellar 
convexity 
5x5x atypical 7% 
38.  hari shankar 
misra 
542011c 26271/04 m 35 I falx 3.5x4.0x4.3  3% 
39.  himanshu 
banerjee 
446698c 15140/04 m 52 I frontal convexity 1.3x1.6x2.6 microcystic 12% 
40.  jabajeya thanka  524541c 29449/04 f 48 I  frontal convexity 3.5x3x3.5 transitional 0.80% 
41.  Jagadish 016597d 17081/07 m 55 I cpangle 5x5x4 fibroblastic 3.80% 
42.  jagnath awon 579529c 1396/05 m 41 I petroclival 4.5x4x3.5 transitional 5% 
43.  jahar la 
chakraborty 
604689c 6946/05 m 51 II  frontoparietal  2x2 atypical 23% 
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44.  Jaya 020651d 17581/07 f 44 I parasagittal 2.9x2.9x2.5  1% 
45.  jharna das 891490c 28588/06 f 34 II tentorial 4x4x4 atypical 20% 
46.  josphine  812540c 13049/06 f 44 II sphenoid wing 3.3X3X3 atypical 6%
47.  justin wheeler 854179c 22028/06 m 44 I sphenoid wing 4x4x5.5 angiomatous 2% 
48.  kajal begum 568000c 29793/04 f 41 II frontal convexity 7x6x6 chordoid 10% 
49.  kalidas 735315c 30829/05 m 54 I olfactrory groove 4.5X3.4x3.9  2% 
50.  kamala addya 830460c 15831/06 f 43 II Parasagittal 6.5x5.7x5.0 atypical 12% 
51.  Kanti 003778d 13104/07 f 35 I frontal convexity 4.7x4.7x6 meningothelial 5.80% 
52.  karuna mondal  487091c 16726/04 f 44 II sphenoid wing 3.9x4.4x4.4 atypical 11.20%
53.  keshia devi 724356c 28655/05 f 63 II  Clinoidal 3X3X4  12% 
54.  krishna mitra 610554c 7678/05 f 56 II  tentorial 6x5x7 atypical 20% 
55.  Lal Mohan  957044C 1591/07 m 33 I Tentorium 5x5.4x5  9% 
56.  lalit mardi 602881c 7081/05 m 20 I parietal 6x6x7 transitional 8.80% 
57.  laxmi devi 525440c 24000/04 f 45 I sphenoid wing 3x4x4.4 meningothelial 1% 
58.  madan mohan  738342c 2240/06 m 62 I  parasagittal 3.9 x3.3x3.6  4.50% 
59.  madhuri sharma 561760c 29796/04 f 40 II pterional 4.3X4X5.2 atypical 16.50%
60.  mahamayamaity 653820c 16392/05 f 50 I parasagittal 8x5x5  2% 
61.  manas kumar 520319c 25267/04 m 41 I Olfactorygroove 4x4x3  5% 
62.  manira khatoon 511007c 25271/04 f 47 I Olfactorygroove 3.5x3x3.5  7.60% 
63.  manju devi 578099c 3481/05 f 41 II planum sphenoidal 3.7X3.2X3.8 atypical 9.80% 
64.  Manora 006256d 13100/07 f 44 I frontal convexity 3.6x3.2x3 fibroblastic 2% 
65.  Mary 991863c 7941/07 f 66 II Parasagittal 7X4X4.2 clearcell 20% 
66.  md golam rasu 657631c 17397/05 m 64 I Tentorium 3x2x3 3%
67.  md.mozammmel 
haque 
612073c 7845/05 m 53 II Olfactorygroove 5.5x6x4.5 transitional 10% 
68.  meena devi 679675c 22147/05 f 45 I Planum sphenoidal 4.5x4.5x4  3% 
69.  mhd abu said 454412c 13320/04 m 49 I petroclival 4.7x4.1x3  1.30% 
70.  mhd israil 457637c 12170/04 m 52 I frontal convexity  microcystic 2% 
71.  Mina  009455d 11533/07 f 28 I tentorium 3x2.2x3.1 transitional 3% 
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72.  mira sil 582696c 2440/05 f 47 I  parasagittal 4.5X4.4X4 transitional 2.80% 
73.  mohammud 
attahullah khan 
696360c 27962/05 m 10 II Clinoidal 3x3.5x2.7 atypical 7.50% 
74.  mohammud 
haurn khan 
679170c 24530/05 m 52 II  parietal 3x4x2.5 transitional 1% 
75.  Monir 022484d 15707/07 m 38 I parasagittal 7.5x5x7 meningothelial 3.20% 
76.  Mosammat 948623c 15478/07 f 36 I frontal convexity 3x3.5x2 transitional 4.40% 
77.  murari 
choudhari 
582163c 1519/05 m 30 II frontal convexity 5X4.5X4 chordoid 12.70%
78.  Murugan 971435c 13715/07 m 37 I parietal 3x2.5x2.5 angiomatous 
meningioma 
4% 
79.  Namita 021839d 14259/07 f 50 I parasagittal 7x7x6  2% 
80.  narang 476159c 14233/04 f 38 I petroclival 4.5x4x3.5  1% 
81.  narayan chandra 229812c 10150/06 m 58 I  pterional 3.3X2.4x3.2 angiomatous 4% 
82.  narayan mallya 563024c 5448/05 m 47 I Tentorium 4.1x4x4.2 fibromatous 2% 
83.  nayeema shad  536024c 26478/04 f 45 I frontal 4.1x3x4.2  2% 
84.  oheward laloo 838976c 17292/06 m 37 II planum sphenoidal 6X5.6X5 atypical 10.80%
85.  om prakash  775964c 7541/06 m 31 I parietal 5x3.4x4.3 microcystic 1% 
86.  pankaj 
chakrabprty 
807582c 13590/06 m 43 I frontal convexity 3.8X3.4X3 transitional 4% 
87.  prabir 
mukherjee 
927700A 21372/04 m 53 I tuberculum sellae 2x2x1.8  1.30% 
88.  Pradip 017377d 13528/07 m 53 I tuberculum sellae 7.3x7x3.5 meningothelial 3.20% 
89.  pratima gorai 593540c 6410/05 f 42 I atrium 3.0x3.6x3 transitional 4% 
90.  r b singh 588146c 27960/05 m 49 I  frontal convexity 3.4X3.54.3  2% 
91.  r.c.choudhary 660861c 18766/05 m 47 II  petroclaval  5x4x2  3% 
92.  rafiqul anwar 566931c 658/05 m 48 I parasagittal 4.2X3.4X2.5 transitional 4.20% 
93.  ramapada 878074c 23898/06 m 22 I sphenoid wing 5x2.5x3  2% 
94.  ramgopal 635617c 13235/05 m 52 I Clinoidal 3x3x3.5 transitional 6%
 Appendix 4 
 
 
 
95.  ranjan mr 587365c 5648/05 m 57 II  CP angle 5.3x 3.3x7 atypical 17.20%
96.  ratna rajbangshi 590956c 3544/05 m 51 I parasagittal 3.7X3.5X4 transitional 11.40%
97.  Ratneswar 994635c 10526/07 m 54 II parietal 3.5X4X2.5 atypical 15%
98.  ravi 040414B 26959/04 m 41 II  parietal 6x4.4x8 atypical 24% 
99.  reba das 830380c 16149/06 f 68 I  parasagittal 6X6X6 fibroblastic 6.50% 
100. rezaul 619489c 10060/05 m 32 I frontal convexity 5.4x6.4x6.7 atypical 1.40% 
101. rina guha 858722c 28702/06 f 48 I sphenoid wing 4.8x3.8x4.3  9% 
102. sachindra dey 652928c 16284/05 m 64 II ant cranial fossa 4x4x2 atypical 15% 
103. sandhya dey 497266c 23606/04 f 40 II parietal 4x3.3x2 chordoid 4% 
104. sanjith rudra pal 851219c 20679/06 m 24 I Falx 6x5.5X6 fibroblastic 3.20% 
105. sarbani banerjee 555136c 28910/04 f 61 I frontal convexity 6.4x5..7x4.4 transitional 3.40% 
106. sefali dey 876529c 28120/06 f 58 II planumsphenoidale 3.5x3.5x3  4.80% 
107. senowara begum 524240c 23008/04 f 50 I parasagittal 4.2x4.9x4 microcystic 1% 
108. shaffrunnissa 775819c 5753/06 f 48 I Clinoidal 4.5x4x4.8  7% 
109. shakuntala maji 530006c 25371/04 f 55 I sphenoid wing 3x2.5x1.5  0.50% 
110. shambu narayan 775090c 5167/06 m 63 I Planum spheoidale 4x4x5  10% 
111. shanmugam 487455c 17004/04 m 51 II parietal 6x4.8x5 atypical 23% 
112. shiv kumari devi 554719c 29976/04 m 50 II  cavernous sinus 3.7X2.8X3 atypical 15.80%
113. shova rani 
chatterjee 
736065c 31216/05 f 54 I planumsphenoidale 4.2x3x3  2% 
114. shyamali ghosh 761520c 6700/06 f 55 II planumsphenoidale 3.8X3.4X3 atypical 9% 
115. sibeswarsha 854484c 20997/06 m 62 I  parietal 3X3 meningothelial 3.60% 
116. soma 
chattopadhyay 
418996c 10838/05 f 33 I  parietal 2.2x2.8x2.6  2% 
117. Sumithra 038647d 17021/07 f 45 II tentorium 2x1.5x2.5 atypical 5% 
118. sumitra rakhshit 476210c 14265/04 f 41 II petroclival 5.8x5.3x5.5 atypical 19% 
119. sunitha 608868c 8259/05 f 22 I frontal convexity 6.6x6.6x8 angiomatomatous 2%
120. syed mhd arif 641869c 14424/05 m 39 II falx 3.5x4x3 atypical 14.50%
121. tabibur rahnman 694615c 23962/05 m 54 I falx 7.4x4x5  2% 
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122. tahsin ali 566524c 30371/04 m 38 I cerebellar 5X4.5X3 transitional 2.50% 
123. tapati basra 531873c 25763/04 f 42 I falx 6x5x4.7 fibroblastic 1% 
124. tusar kanti 
maetya 
727633c 15147/06 m 48 I cpangle 4.4X4.3  4% 
125. Uma  985950C 9637/07 f 54 I cpangle 3.3X4.2X5 fibroblastic 2% 
126. uttam pal 703263c 24812/05 m 38 I  frontal convexity 5x4x5 microcystic 1.50% 
127. vannamayil 772872c 23822/6 f 46 II Tentorium 4X5x6 atypical 8.50% 
